pbogaty cv 2015-01-19 cliniccliniquecardiomontreal.com/bogatycv.pdf · cv peter bogaty en date du...

CVPeterBogatyendatedu15janvier2017

Diplomas and Titles

M.D. University of Liège, Belgium, 1980 L.M.C.C. (Canadian Medical Licensing Examinations), 1983 Diplomate in Internal Medecine, American Board of Internal Medicine, 1986 C.S.P.Q. Médecine Interne (Quebec Internal Medicine Examinations), 1987 F.R.C.P.C. (Fellow, Royal College of Physicians, Canada), Internal Medecine, 1987 F.R.C.P.C. (Fellow, Royal College of Physicians, Canada) Cardiology, 1988 C.S.P.Q. Cardiology (Quebec-certified Cardiologist), 1989 Diplomate in Cardiovascular Medecine, American Board of Internal Medicine, 1989

Present Status Member of the « Event Adjudication Committee » of the ORIGIN study, McMaster University, Hamilton, Ontario 2011- Member of the « Event Adjudication Committee » for the SCOUT Study (Sibutramine Cardiovascular Outcomes Trial) 2003-2010 Medical Advisor of the Cardiac Evaluation Unit of the Quebec Health Technology Evaluation Agency (Agence d'évaluation des technologies et des modes d'intervention en santé) (AETMIS) 2005 - Member of the Advisory Committee for the National and International Classification of diseases (ICD-10) for the Canadian Institute for Health Information 2007-2010 Member of the RUIS Committee in Cardiology 2006- “Professeur agrégé” (Associate Professor) Département de médecine Université Laval Québec, Québec Clinical Cardiologist (with privileges at the Institut universitaire de cardiologie et de pneumologie de Québec and Sorel Hospital) (License no 183-581 in the province of Quebec) 1991- Member of the Editorial Board of the Canadian Journal of Cardiology 2002-2011

Updated:JANUARY5,2017

of 44

Member of the Canadian Cardiovascular Society Member of the American Heart Association / American Stroke Clinical Cardiology Council

Activities of Institut national d’excellence en santé et en services sociaux

(INESSS)

Peter Bogaty, MD Conseiller scientifique Unité de cardiologie

• Évaluations-terrain sur le traitement de reperfusion dans l’infarctus du myocarde avec

élévation ST au Québec

• Évaluation-terrain sur le remplacement des défibrillateurs implantables au Québec

• L’utilisation des dispositifs d’assistance ventriculaire gauche de longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec/ Évaluation-terrain en cours

• Implantation percutanée de la valve aortique (TAVI) / ÉVALUATION TERRAIN en

cours

• Pontage aorto-coronarien & intervention coronarienne percutanée (PAC-ICP) en cours

•

Rapports publiés

l’Institut national d’excellence en santé et en services sociaux (INESSS)

Rapports rédigé par L’Unité d’évaluation cardiovasculaire (UECV)

• Évaluation des défibrillateurs cardiaques implantables avec sonde sous-cutanée https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_Evaluation_defibrillateur_cardiaque_impl_sonde_sous-cutanee.pdf

Rapport publié en novembre 2016

https://www.inesss.qc.ca/a-propos/notes-biographiques/note-biographique/peter-bogaty.html


of 44

• Portrait de la prise en charge de l’infarctus aigu du myocarde avec élévation du segment ST au Québec en 2013-2014 : résultats d’une troisième évaluation terrain à l’échelle provinciale https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_Portrait_Provincial_IAMEST.pdf

Rapport publié en septembre 2016

• Traitements de reperfusion de l’infarctus aigu du myocarde avec élévation du segment ST (IAMEST) et réduction des délais: mise à jour de la littérature https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_Etat_Connaissances_IAMEST.pdf

Rapport publié le 17 octobre 2016

• Normes relatives aux traitements de reperfusion de l’infarctus aigu

du myocarde avec élévation du segment ST (IAMEST) au Québec https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_Normes_de_qualite_IAMEST.pdf

Rapport officielle : 6 septembre 2016

• Portrait de l’utilisation et des résultats cliniques de l’implantation valvulaire aortique par cathéter (TAVI) au Québec : résultats d’une évaluation sur le terrain à l’échelle provinciale en 2013-2015 https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_TAVI_2016.pdf

Rapport publié avril 2016

• L'utilisation des dispositifs d'assistance ventriculaire gauche de longue durée pour le traitement de l'insuffisance cardiaque avancée au Québec de 2010 à 2012 https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/INESSS_DAV_ResultatsEvaluationTerrain.pdf

Rapport publié le 15 janvier 2015






of 44

ETIAMEST I et II : Faits saillants

Domaine d'expertise: Cardiologie

Rapport publié le 31 mars 2014

ETIAMEST (Évaluation terrain de la prise en charge de l’infarctus aigu du myocarde avec élévation du segment ST, ou IAMEST) est un projet phare de l’Unité d’évaluation en cardiologie tertiaire (UECT). Il vise à dresser le portrait réel de la prise en charge de l’IAMEST au Québec à l’échelle provinciale, régionale et dans les établissements afin d’améliorer les résultats cliniques. En 2014, l’Unité entreprendra la phase III de collecte des données au niveau provincial. Ces données, combinées à celles recueillies aux phases I et II, permettront de suivre l’évolution de la performance de la prise en charge de l’IAMEST. L’Unité a d’ailleurs complété cette année l'analyse en profondeur des données relatives aux phases I et II du projet. Il s’en dégage des constats importants, tant en ce qui concerne l’organisation des soins que les décisions cliniques qui interviennent dans la prise en charge de l’IAMEST.

Réviseur externe: 'Portrait de l'usage du dabigatran chez les personnes assurées par le régime d'assurance médicaments' INESSS février 2013

Institut national de santé publique du Québec et l’Institut national d’excellence en santé et en services sociaux (INESSS). Évaluation des soins et surveillance des maladies cardiovasculaires : Pouvons-nous faire confiance aux données médico-administratives hospitalières ? Claudia Blais, Laurie Lambert, Denis Hamel, Kevin Brown, Stéphane Rinfret, Raymond Cartier, Maude Giguère, Céline Carroll, Christiane Beauchamp et Peter Bogaty. Montréal, Qc : INESSS ; 2012. Rapport publié le 11 octobre 2012

Impact: il est important et pertinent de valider si les données medico-administratives au Québec peuvent être utilisées avec confiance pour évaluer les actes médicaux, les profils cliniques des patients, et les issus cliniques

Institut national d’excellence en santé et en services sociaux (INESSS). Evaluation of the

evidence on the HeartMate II® and HeartWare® ventricular assist devices for the treatment of chronic end-stage heart failure. Georgeta Sas, Lucy J. Boothroyd, Jason R. Guertin, Laurie J. Lambert, Jean E. Morin, Hadi Chakor et Peter Bogaty. INESSS 2012; 8(15): 1-166. Impact: Projet mandaté par le MSSS pour évaluer l’évidence sur les benefices, risques, et implications organisationelles et économiques des dispositifs d’assistance ventriculaire (‘coeurs mécaniques’). Les données de ce rapport fournissent une aide aux decisions quant à l’utilisation de cette technologie au Québec Institut national d’excellence en santé et en services sociaux (INESSS). Implantation valvulaire aortique par cathéter. Évaluation des données probantes et synthèse des considérations organisationnelles. Rédigé par Marco Spaziano, Lucy J. Boothroyd, Jason R. Guertin, Hadi Chakor, Yongling Xiao, Laurie J. Lambert et Peter Bogaty. INESSS 2012; 8(8): 1-84.

Impact: Projet mandaté par le MSSS pour évaluer l’évidence sur les benefices, risques, et implications organisationelles et économiques de l’implantation par voie percutanée des valves aortiques; un rapport pour aider le MSSS dans les prise des decisions quant à l’introduction et l’utilisation de cette technologie au Québec

Lambert L, Brown K, Samek D, David K, Bogaty P. Le fichier Med-Echo du Québec est-il la source de données appropropriées pour dénombrer les interventions coronarienne percutanées (ICP). Publié le 13 septembre 2011.


of 44

http://www.inesss.qc.ca/index.php?id=65&L=1&user_inesssdoc_pi1%5Bcode%5D=FICHE&user_inesssdoc_pi1%5Buid%5D=1313&user_inesssdoc_pi1%5BbackUrl%5D=index.php%253Fid%253D49%2526no_cache%253D1%2526L%253D1&cHash=9630954feaf9c44093bf4df3b93947b8

Impact: Un rapport qui a mis en evidence une sérieuse lacune quant à la capacité de la banque medico-administrative MedEcho de bien comptabiliser le nombre des procedures percutanées coronariennes (ICP) en raison d’une différence dans le façon que les centres hospitaliers au Québec offrant l’ICP définissent des admissions. Cette information nouvelle aidera à uniformiser la definition d’une admission hospitalière afin de recenser correctement le nombre des ICP réalisées au Québec.

Boothroyd LJ, Lambert L, Bogaty P, Evidence meets context: a case study in an evaluation of care for acute myocardial infarction. Part 1 and 2. ID : 11778/11779. Présentation HTAi 2008, AETMIS/RQCT 2008. http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml

Bogaty P, Boothroyd LJ, Lambert L, Lance JM, Paquette D. Organizational and Economic Issues in the Management of Patients with Acute ST-segment Elevation Myocardial Infarction (STEMI): Summary. AETMIS 2008. http://www.aetmis.gouv.qc.ca/site/en_publications_2008.phtml

Bilodeau C, Giguère M, Lambert L, Bogaty P. Implementation of a province-wide fi eld evaluation of the management of acute myocardial infarction with ST segment elevation in Québec hospitals. ID : 11831/11832. Présentation HTAi 2008, AETMIS/RQCT 2008. http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml

Lambert L, Bogaty P, Bilodeau C, Giguère M, Boothroyd LJ, Morin J. Management of acute myocardial infarction with ST-segment elevation (STEMI) in the Québec context: Preliminary results of a field evaluation (ETIAMEST) and their usefulness for decision-makers. Part 1 and 2. ID : 11780/11781. Présentation HTAi 2008, AETMIS/RQCT 2008. http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml Lambert L, Brophy JM, Boothroyd LJ, Bogaty P. The performance of percutaneous coronary interventions in hospitals without on-site cardiac surgery : Review of guidelines and analysis of Quebec data from 1994 to 2004. ID : 11833/11834. Présentation HTAi 2008, AETMIS/RQCT2008. http://www.aetmis.gouv.qc.ca/site/en_equipe_cardiologie.phtml Lambert L, Brophy JM, Bogaty P. Rapport sur la revascularisation coronarienne par pontage et par angioplastie chez les personnes âgées. AETMIS/MSSS/RQCT 2005-2007. Lambert L, Erickson L, Brophy JM, Bogaty P. Rapport sur l’ouverture de salles d’hémodynamie sans support chirurgical sur place: Partie II. Revue de la littérature. AETMIS/MSSS 2006-2007. Lambert L, Bogaty P. Rapport sur l’ouverture de salles d’hémodynamie sans support chirurgical sur place: Partie II. Évaluation des résultats au Québec 1999-2004 des centres avec versus sans rapport chirurgical sur place . AETMIS/MSSS 2006-2007. Perron S, Huynh T. (Bogaty P, consultant) Rapport sur le traitement de l’infarctus avec élévation du segment ST : Partie I. Analyse des registres et méta-analyses. AETMIS/MSSS 2006-2007.

Lambert L, Boothroyd L, Paquette D, Bogaty P. Rapport sur le traitement de l’infarctus avec élévation du segment ST : Partie II. Dimension contextuelle. AETMIS/MSSS 2006-2007


https://www.inesss.qc.ca/en/about-us/biographical-notes/biographical-note/peter-bogaty.html


of 44

Previous Posts

Senior Clinical Research Scholar of the FRSQ (Fonds de Recherche en Santé du Québec) 2002-2004 Director of the Quebec Heart Institute, 1999-2003 Chief of the Department of Cardiology. Laval Hospital, 1999-2003 Director, Coronary Care Unit Quebec Heart Institute / Laval Hospital 1991-2003 Member of the Research Committee at the Quebec Heart Institute 1998-2005 Staff Cardiologist, Maisonneuve-Rosemont Hospital, Montreal, April-August, 1991

Previous Status

Junior Clinical Research Scholar "Fonds de Recherche en Santé du Québec" (FRSQ) 1992-96 Cardiology Research Fellow, Cardiovascular Research Unit (Professor Attilio Maseri) Royal Postgraduate Medical School, Hammersmith Hospital, London, UK, 1989-91 Residency in Cardiology, Quebec Heart Institute, Laval Hospital, Laval University, Quebec, 1987-88 Residency in Cardiology, Montreal Heart Institute, University of Montreal, 1986-87 Residency in Internal Medicine, Laval University, Quebec, 1984-86 Rotating Internship, Laval University, Quebec, 1982-83 Residency in Internal Medicine, Joseph Wauters Hospital, (Liège University), Waremme, Belgium, 1980-82


of 44

Committees and Memberships Representative of INESSS at meetings of the of the Quebec Tertiary Cardiology Network 2007 - to present Member of the Advisory Committee for the National and International Classification of diseases (ICD-10) for the Canadian Institute for Health Information 2007- Member of the RUIS Committee in Cardiology 2006- President of the Scientific Committee of the Quebec Tertiary Cardiology Network 2004-2007 Member of the Executive Committee of the FRSQ-sponsored Cardiovascular Network 2004-2006 President of the Acute Coronary Care Working Group of the Quebec FRSQ-Sponsored Cardiovascular Network 1998-2004 Member of the Canadian Working Group of the Canadian Vascular Society for the Adaptation to Canada of the The American College of Cardiology (ACC) / American Heart Association (AHA) Guidelines for the Management of Patients with ST Segment Elevation Myocardial Infarction 2004 External Peer Reviewer for the The American College of Cardiology (ACC) / American Heart Association (AHA) Guidelines for the Management of Patients with ST Segment Elevation Myocardial Infarction 2003 Member of the evaluating committee for the ‘Fonds de la santé du Québec’ (FRSQ) research scholarship program 2004 Member of the Editorial Board of the Canadian Journal of Cardiology 2002- Member of the Event Adjudication Committee for the SCOUT Study (Sibutramine Cardiovascular Outcomes Trial) 2003- Member of the Canadian Cardiovascular Society Member of the American Heart Association / American Stroke Clinical Cardiology Council Member of the American Heart Association / American Stroke Association Arteriosclerosis, Thrombosis & Vascular Biology Council Member of the Quebec Heart Institute Research Committee, 1998- Member of the Executive Committee of the Quebec Tertiary Cardiology Network 2000-2003 Member of the Advisory Committee for AETMIS (Agence d’Évaluation des Technologies et des Modes d’Intervention en Santé) on Positron Emission Tomography 2001-2002 Member of the CCS Consensus Conference 2002: Management of Heart Disease in the Elderly Patient; Management of Acute Coronary Syndromes in the Elderly 2002 Member of the Primary Panel of the Canadian Cardiovascular Society Consensus on Angina Pectoris (1996-97) (Can J Cardiol 1998;14 (Suppl C):1C-24C)


of 44

Member of the Cardiopulmonary and Critical Care Council of the American Heart Association 1995-2000 Member of the ad hoc Positron Emission Tomography Committee, Laval Hospital, 1997-2003 President of the Resuscitation Committee, Laval Hospital, 1994-2003 Member of the Nominating Committe for the Directorship of the Quebec Heart Institute, 1997-1998 Member of the Committee of Admission Standards, Laval Hospital, 1995-1997 President of the CMDP ad hoc Committe of Laval Hospital for the Evaluation of Treatment of Morbid Obesity by Biliopancreatic Derivation 1995-96


of 44

Teaching Activities

Worshop on ‘Ischemic Heart Disease’ Epidemiology course (EPM-7018 : Épidémiologie des grands problèmes de santé) Université Laval, 12 octobre 2016 Cardiovascular disease, epidemiology course animation, Laval University (EPM-7018), Quebec, October 7, 2015 Animateur du cours EPM-7004 : Recherche appliquée au domaine de la santé. Université Laval 2009 – 2013 Member of the Examination Committee for the Master thesis of Olivia Drescher, Laval University, 2009 Professeur contribuant au cours en épidémiologie et santé publique du 1er cycle EPM-62616-A et SAC-67322-A Recherche appliquée au domaine de la santé. 2007- ongoing Faculty of Medicine; Laval University, course on Ischemic Heart Disease to first-year students (12h/year) 1995-2007 Workshop on cardiovascular disease, Laval University, [Epidemiology of major healthcare problems (EPM-66599)], Maladies circulatoires - Maladies ischémiques du cœur, October 11, 2006 Member of the evaluating committee for the thesis of Julie Methot, December 16, 2005; Maladie coronarienne chez la femme: influence des hormones et du polymorphisme insertion/délétion du gène de l’enzyme de conversion de l’angiotensine Supervision of Naji Wakil, medical student attending Laval University – research project of serial angiograms in the study RISCA 2005- Workshop on cardiovascular disease, Laval University, [Epidemiology of major healthcare problems (EPM-66599)], October 12, 2005 Director of master of science training and thesis of Ms Audrey Marcoux 2004-5 Director of PhD student Martin Noël (‘Investigation sur le préconditionnement et l’entraînement du myocarde ischémique’) 2003-7 Evaluator of the MSc thesis of Marie-Pierre Dumas, July 2004 (Influence of cardiovascular medication on the results of the dobutamine stress echocardiogram in normal subjects) Co-director of Dr Phung Nguyen Xuan’s master degree, Laval University, 1996-1999 Co-supervisor of Dr Paola Muré, research program, 1993-1994 Member of the Predoctoral Examination Committee of Claudia Blais (‘Étude dynamique de la sténose aortique’) July 2001 Member of the Examination Committee for the doctoral thesis of Denis Boucher, Laval University, 1999


of 44

Course on Acute and Chronic Coronary Heart Disease (10h/year) to residents and fellows in cardiology,1995-2003 Teaching Rounds in the Coronary Care Unit (residents in internal medicine and cardiology), Laval Hospital 1991-


of 44

Meetings & Invited Speaker Activities

Présentation au Congrès annuel de médecine, Médecins francophones du Canada Une évaluation terrain de la prise en charge des IAMEST au Québec : résultats pour les 13 centres dotés de salles d'hémodynamique Montréal, 16 octobre, 2015 Présentation au Congrès annuel de médecine, Médecins francophones du Canada Une évaluation terrain sur l'ensemble du Québec de l'organisation des services de l'AVC ischémique en phase hyper aiguë - résultats préliminaires Montréal, 16 octobre, 2015 Presentation at the 45th Annual Course in Drug Therapy, McGill University, Montreal, May 9th 2014. How to Incorporate Guidelines into Practice: Promises and Pitfalls Création d’un registre provincial pour l’évaluation de l’utilisation des DAV au Québec Présentation à ICM et (16 janvier 2013) Présentation à RHV (23 janvier 2013) Présentation à l’IUCPQ (24 janvier 2013) Les enjeux de l’utilisation des dispositifs d’assistance ventriculaire à longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec Présentation par webinaire (26 février 2013) Création d’un registre provincial pour l’évaluation de l’utilisation des DAV au Québec Présentation au Comité scientifique permanent de l’INESSS (22 mars 2013) Characteristics and outcomes of multivessel CAB patients in Quebec Approach annual meeting 2013 Portrait préliminaire de l’utilisation des dispositifs d’assistance ventriculaire à longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec 2011-2012 Rencontre avec le MSSS (30 avril 2013) Portrait préliminaire de l’utilisation des dispositifs d’assistance ventriculaire à longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec (1 janvier 2011- 31 décembre 2012) Présentation DAV ICM (22 mai 2013) Présentation DAV Laval (23 mai 2013) Présentation DAV RHV (10 juin 2013) L’option d’un cœur mécanique pour le patient avec insuffisance cardiaque terminale : revue systématique pour guider une prise de décision éclairée Présentation 2e congrès international des soins palliatifs (2 mai 2013) Use of LVAD in the treatment of end-stage heart failure: Results of a systematic literature review and a Quebec field evaluation Présentation RVH (29 août 2013) Une évaluation systématique de la prise en charge de l’AVC ischémique et de l’IAMEST au Québec Présentation au Comité consultatif AVC (11 sept. 2013)


of 44

Portrait préliminaire de l’utilisation des dispositifs d’assistance ventriculaire à longue durée (DAV) pour le traitement de l’insuffisance cardiaque avancée au Québec (1 janvier 2011- 31 décembre 2012) Presentation DAV à l’Institut de Cardiologie de Montréal (22 mai 2013) Presentation DAV Institut universitaire de cardiologie et de pneumologie de Québec (23 mai 2013) Presentation DAV Royal Victoria Hospital (10 juin 2013) Portrait préliminaire de l’utilisation des dispositifs d’assistance ventriculaire à longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec 2011-2012 Rencontre avec le MSSS (30 avril 2013) Atelier aux médecins généralistes sur la cardiologie de première ligne au bureau. Fontainebleau, April 10, 2013 Canadian Institute for Health Information; Classification Advisory Committee meeting, Ottawa, Ontario, April 5, 2013 Création d’un registre provincial pour l’évaluation de l’utilisation des DAV au Québec Présentation au Comité scientifique permanent de l’INESSS (22 mars 2013) Les enjeux de l’utilisation des dispositifs d’assistance ventriculaire à longue durée pour le traitement de l’insuffisance cardiaque avancée au Québec. Présentation par webinaire (26 février 2013) Presentation à l’Institut universitaire de cardiologie et de pneumologie de Québec; création d'un registre provincial pour l'évaluation de l'utilisation des DAV au Québec (INTERMACS). Québec, January 24, 2013 Presentation at the Institut de cardiologie de Montréal (ICM); création d'un registre provincial pour l'évaluation de l'utilisation des dispositifs d’assistance ventriculaire (DAV) au Québec (INTERMACS). Montréal, January 16, 2013 Presentation at the Réseau québecois de la cardiologie tertiaire (RQCT); Plan quinquennal UECT 2013-2018. Drummondville, December 5, 2012 Presentation at the Region 03 (Quebec); Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. Québec, December 4, 2012 Présentation at the Ministère Santé et Services Sociaux (MSSS), Réseau universitaire intégré de santé (RUIS), Réseau québecois de la cardiologie tertiaire (RQCT), Directeur des services professionnels (DSP), Conseil des médecins du Québec (CMQ), Agences, Association des médecins d'urgence du Québec (AMUQ), Association des cardiologues du Québec (ACQ), Vice-doyen université de Sherbrooke et université de Montréal. Videoconference from Montreal, November 27, 2012 Présentation at the 1er colloque sur la recherche scientifique préhospitalière; Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. Ville LaSalle, November 23, 2012 Presentation at the Côte-Nord Region via vidéoconference; Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. Montreal, November 20, 2012


of 44

Presentation at the Outaouais Region; Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. Gatineau, November 20, 2012 Presentation at the Scientific Transcatheter Aortic-Valve Implantation (TAVI) committee; Évaluation terrain de TAVI. Montreal, October 17, 2012 Presentation at the Comité Scientifique Permanent en Santé et en Services Sociaux(CSPSSS); Évaluation terrain sur l'utilisation des dispositifs d'assistance ventriculaire au Québec (2008-2012). Montreal, September 28, 2012 Presentation at the Region 15 (St-Jérome); Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. September 27, 2012 Presentation at the Region 16 (Montérégie); Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. September 21, 2012 Presentation at the Scientific Comittee for the dispositifs d’assistance ventriculaire (DAV); Protocole / Diffusion du rapport ministériel au Québec et à l'extérieur de Québec. Montreal, September 19, 2012 Presentation at the development day for the AGISQ (Association des Gestionnaires d'Information de la Santé du Québec) (Quebec archivistes), Rôle des gestionnaires de l’information de la santé du Québec dans l’excellence clinique: Expérience pratique de l’unité d’évaluation en cardiologie tertiaire de l’Institut national d’excellence en santé et en services sociaux, Hilton Hotel, Montreal, May 10, 2012 Presentation at the Region 04 Mauricie et centre du Québec; Résultats d’une évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. Trois-Rivières, May 4, 2012 Presentation at the Scientific Comittee for the dispositifs d’assistance ventriculaire (DAV); Projet d’évaluation de Dispositifs d’assistance ventriculaire implantables. Montreal, April 23, 2012 Presentation at the Direction nationale des urgences; Résultats d'une évaluation systématique de la prise en charge d'IAMEST au Québec. Montreal, April 16, 2012, Presentation at the Réseau québecois de la cardiologie tertiaire (RQCT); Évaluation systématique de la prise en charge d'IAMEST au Québec; Mise à jour des activités de l'UECT Implantation valvulaire aortique par cathéter (TAVI); Mise à jour des activités de l'UECT Pontage aorto-coronarien et interventions coronaires percutanées (PAC/ICP). Drummondville, March 13, 2012 Presentation at the Ministère Santé et Services Sociaux (MSSS); Évaluation des données probantes sur les dispositifs d’assistance ventriculaire gauche HeartMate II® et HeartWare® (DAV) pour le traitement de l’insuffisance cardiaque chronique en stade terminal. Quebec, February 22, 2012 Presentation at the Ministère Santé et Services Sociaux (MSSS); Évaluation systématique de la prise en charge de l’infarctus aigu du myocarde avec elevation du segment ST au Québec. Québec, February 15, 2012


of 44

Presentation at the Ministère Santé et Services Sociaux (MSSS); Évaluation terrain de la prise en charge de l’infarctus aigu du myocarde avec élévation du segment ST. Montreal, October 13, 2011 Invited speaker at the McGill Centre for Continuing Education. Atrial Fibrillation. Jewish General Hospital, Montreal, May 12, 2011 Invited professor, speaker at Cardiology Programme, Université de Montréal, ST Elevation myocardial: thrombolysis. Hôpital du Sacré-Coeur, Montreal April 12, 2011 Invited speaker, importance of common data definitions at the Institut national d’excellence en santé et en services sociaux (INESSS). The Canadian Cardiovascular Data Definitions and Quality Indicators Project, Toronto 11 mars 2011 Invited speaker at the Table des directeurs médicaux régionaux des services préhospitaliers d'urgence. Résultats des analyses concernant la prise en charge des infarctus du myocarde avec élévation du segment ST. Ville LaSalle 16 février 2011 A systematic province-wide field evaluation ST-Elevation Myocardial Infarction (STEMI) care. Colloque du département d'épidémiologie de l'université McGill. Montréal 27 janvier 2011 Invited expert at the meeting of Urgences Santé. ETIAMEST II : les aspects préhospitaliers. Montréal 10 nov 2010 Invited expert at the CCORT Annual National Meeting. Toronto May 3-4 2010 Chair scientific session at the Vascular Protection Forum 2010. Toronto, June 4-5 2010 Invited speaker at the Quebec Society of Vascular Sciences. Continuing Health Education Program, afternoon symposium Lipids 2010. The usefulness of high sensitivity C-Reactive Protein in the evaluation of CV risk. Montreal, January 15th, 2010. Invited speaker at McGill University Health Centre, division of Clinical Epidemiology Seminar Series. Field Evaluation of Myocardial Infarction with ST-Elevation in Quebec. Montreal, October 29, 2009 Bogaty P, Lambert L, Bilodeau C. RQCT, table de concertation annuelle. Trois-Rivières, June 7, 2009. Bogaty Peter (con). Debate at the Vascular Protection Forum: CRP should be part of the risk assessment of our patients. Toronto, May 30, 2009. Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), videoconference, Montréal, 19-Mar-09, Abitibi Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Beauce, 26-Feb-09, Chaudière-Appalaches Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Hull, 3-Feb-09, Outaouais Agency (Hull)


of 44

Invited speaker at St-Michael’s Cardiac Research Rounds. « Atherosclerosis, Inflammation and Biomarkers: What is the Fit? » Toronto, Ontario, January 26, 2009 Invited speaker at St-Michael’s Cardiac Grand Rounds. « To CRP or not to CRP ». Toronto, Ontario, January 26, 2009 Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 22-Jan-09, Montréal region Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), visioconference, Montréal,15-Jan-09, Lac St-Jean Lambert L, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 15-Jan-09: Presentation at the Montreal Heart Institute Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), 16-Dec-08, Laval Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec, 15-Dec-08, Québec region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Trois-Rivières, 9-Dec-08, Mauricie/Quebec centre region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), videoconference, Montréal, 28-Nov-08, Bas St-Laurent region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Longueuil, 20-Nov-08, Montérégie region Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 3-Nov-08: Tertiary Cardiology and RUIS Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal,10-Oct-08: Presentation to the DSPs Lambert L, Giguère M, Bilodeau C, Bogaty P . RResults STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec, 9-Oct-08: Presentation at DRAMU (Directeur Régional des Affaires Médicales et Universitaires). Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Drummondville, 6-Oct-08: Presentation at Réseau Québecois de cardiologie tertiaire (RQCT).


of 44

Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Montréal, 2-Oct-08; Presentation at the RUIS Lambert L, Giguère M, Bilodeau C, Bogaty P. Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec,10-Sep-08: Presentation at Ministère de la Santé et Services Sociaux (MSSS). Lambert L, Giguère M, Bilodeau C, Bogaty P. HTAi, Montréal, Jul-08, HTAi convention Lambert L, Giguère M, Bilodeau C, Bogaty P. Preliminary Results STEMI Field Evalutation Study (ETIAMEST: étude terrain sur l’infarctus aigu du myocarde avec élévation du segment ST), Québec, 5-Jun-08: Presentation at Ministère de la Santé et Services Sociaux (MSSS). Presentation of a Workshop in Coronary Artery Disease Management at the Vascular Protection Forum, Toronto, May 31, 2008. Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT): STEMI Field Evalutation (ETIAMEST). Montréal, September 25, 2007 Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT): Coronary angioplasty in hospitals with and without cardiac surgery. Montréal, September 25, 2007 Invited speaker at the Scientific Committee of the Quebec Tertiary Cardiology Network ( RQCT): Coronary revascularisation in aged patients in Québec. Montréal, November 20, 2007 Invited speaker at the Agence d'évaluation des technologies et des modes d'intervention en santé. AETMIS. Coronary angioplasty in hospitals with and without cardiac surgery. Presentation to hospital directors (directeurs des services professionnels), Montréal, September, 2007 Participation at a meeting for a project of collaboration between l'INSPQ (Institut national de santé publique au Québec)e t l'AETMIS for the validation of Quebec hospital medico-administrative databases to establish monitoring and evaluation in cardiology. Agence d'évaluations des technologies et des modes d'intervention en santé. AETMIS, Montreal, July 27, 2007 Participation at the CIHR cardiac waiting times meeting,Ottawa, Ontario, July9, 2007 RQCT annual meeting presentation of AETMIS Cardiac Evaluation Unit activities. Montréal,19 juin 2007 Participation at the « Vascular Protection Forum » - - Prevention of vascular, renal, and metabolic abnormalities: Implications of the renin angiotensin aldosterone system. Toronto, Ontario, June 9, 2007 Invited speaker at the medicine department: 'Le traitement de l'infarctus du myocarde avec élévation du segment ST'. Ste-Agathe des Monts Hospital, April 17, 2007 Invited speaker at the Epidemiology department: In quest of the holy grail: Prediction in coronary artery disease. Royal Victoria Hospital, McGill University Health Center, March 8, 2007 Invited speaker at the medicine department: 'Le traitement de l'infarctus avec élévation du segment ST relève-t-il idéalement de la cardiologie tertiaire? Drummondville, January 16, 2007


of 44

Invited speaker at the emergency and medicine department : l’infarctus du myocarde avec élévation du segment ST : Est-ce que le traitement idéal relève de la cardiologie tertiaire? Hôtel-Dieu de Sorel, Boucherville, November 28, 2006 Invited speaker at the emergency and medicine department of Hôtel-Dieu d’Arthabaska : l’infarctus du myocarde avec élévation du segment ST : Est-ce que le traitement idéal relève de la cardiologie tertiaire? Hôtel-Dieu d’Arthabaska, Victoriaville, October 16, 2006 Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie tertiaire): Résultats de l’étude sur la revascularisation chez les personnes âgées de plus de 80 ans. June 20, 2006 Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie tertiaire): Avis sur l’efficacité et l’efficience de la thrombolyse et de l’angioplastie primaire dans le traitement de l’infarctus aigu du myocarde avec élévation du Segment ST. June 20, 2006 Invited speaker at the Consultation Round Table of the RQCT (Réseau québécois de cardiologie tertiaire): Évaluation-terrain du traitement de l’infarctus du myocarde avec élévation du Segment ST. June 20, 2006 Invited speaker at the cardiology department of McGill University Health Centre; Montreal General Hospital: Acute ST-Elevation Myocardial Infarction (STEMI): Is PCI for all ideal? May 10, 2006 Invited speaker at the 2005 annual meeting and Symposium of the Canadian Association of Cardiac : Issues in Cardiac Rehabilitation & Prevention; Training above the ischemic threshold / A World to Know Better. CCS Montreal, October 23, 2005 Invited speaker to the symposium Advances in cardiology : CRP-Targeted Therapy Offers a Marginal Advantage over Aggressive LDL Reduction. CCS Montreal, October 22, 2005 Discussant at a Roundtable at the 14th Interventional Cardiology Symposium on thrombolysis and PCI, Montreal (Montreal Heart Institute) June 18, 2005. Invited Speaker to the 14th Interventional Cardiology Symposium : Acute Myocardial Infarction Reperfusion Strategies (STEMI Guidelines) : A case for Thrombolysis, Montreal (Montreal Heart Institute) June 18, 2005. Invited Speaker to the 10th Annual Atlantic Canada Cardiovascuar Conference : Evidence, Guidelines and Common Sense, Dalhousie University Faculty of Medicine Halifax April 15-16, 2005 Invited Speaker to the 10th Annual Atlantic Canada Cardiovascuar Conference : Acute Management : Direct Intervention of Thrombolysis ; Management of Acute STEMI in 2005, Dalhousie University Faculty of Medicine Halifax April 15-16, 2005 Invited Speaker at a meeting organized by the emergency physicians of the Centre hospitalier du Haut-Richelieu on the contemporary treatment of acute myocardial infarction March 31, 2005 Invited Speaker at the Grand Rounds of the department of medicine of Charles LeMoyne Hospital : Treatment of ST elevation Myocardial Infarction; what is the evidence for the best treatment. Montreal March 24, 2005 Presenter at the Eastern Regional Atorvastatin Consultancy Committee Meeting (PROVE-IT; Opposing Viewpoint) Montreal February 9, 2005


of 44

Invited Speaker at JANUS VIII: Optimizing Current Pharmacotherapy in ST Elevation Myocardial Infarction, Whistler January 21, 2005 Invited Speaker for emergency and cardiology department of Hôtel-Dieu de Québec Hospital; Le traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS, Quebec, January 18, 2005 Invited Speaker for the internists at Centre Hospitalier Régional du Grand-Portage: Le traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS, Rivière-du-Loup, December 15, 2004 Invited Speaker at the annual meeting of the cardiology department, Centre Hospitalier de l’Université de Montréal (CHUM); Le traitement de l’infarctus aigu du myocarde en 2005 suite aux recommandations de l’AHA/ACC/CCS, Un débat scientifique. Montreal, Vogue Hotel, November 20, 2004 Invited Speaker for Canadian Working Group of the Canadian Cardiovascular Society: Choosing Reperfusion Therapy / Convalescent Evaluation, Calgary October 25, 2004 Invited Speaker at the emergency and cardiology department, Saint-François d’Assise Hospital; Infarctus du myocarde avec élévation ST: thrombolyse et angioplastie primaire, Quebec, October 21, 2004 Invited Speaker at the 6th National Atherosclerosis Forum; Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease, Toronto, September 2004 Invited Speaker at the Canadian Cardiovascular Society, Meet-the-Expert-session, Calgary Workshop Proposal: Biomarkers in the Management of Acute Coronary Syndromes, October 25, 2004 Invited Speaker at the Canadian Cardiovascular Society, Meet-the-Expert-session, Calgary Workshop: Introducing the Canadian Working Group Adaptation of the AHA/ACC 2005 Guidelines on the Management of ST Elevation Myocardial Infarction, October 25, 2004 Invited speaker at JANUS VII, Contemporary Cardiovascular Medicine with a View to the Future, Aging in the Cardiovascular System: Physiologic Change or Pathophysiologic Inevitability? Jamaîca, January 18, 2004. Invited speaker at the Ground Rounds, Montreal Heart Institute: Inflammation et maladie coronarienne : promesse et problématique, October 2, 2003 Invited speaker at the 5th annual convention of the « National Atherosclerosis Forum » Halifax, September 19-21 2003 Invited speaker at Laval University for the presentation of project for the creation of a center on the prevention of cardiovascular disease , Université Laval, May 5, 2003 animation of a ‘Brunch’ for the Quebec Heart Insitute at the PPMC of Laval Hospital, december 1, 2002 (Theme: Prevention in cardiovascular heart disease) Invited speaker at a scientific conference at l’INSERM in Paris, for the FRSQ : Maladie coronarienne et inflammation, November 6, 2002


of 44

Organisation and animation of the 'Retraite de l’Institut de cardiologie de Québec', Lac Delage Manor, Quebec, November 2, 2002 President of a session at the 29th International Convention of Electrocardiology on cardiac monitoring and Acute Coronary Heart Syndrome ,Montreal, July 4, 2002 Presentation au Colloque annuel de formation médicale de l'Association des médecins omnipraticiens de Québec, 26 avril, 2002 à Québec sur 'Les nouveaux facteurs de risque de la maladie coronarienne" Invited speaker of a session for the cardiologist association of Quebec regional scientific conference : "Les nouveaux facteurs de risque de la maladie coronarienne" Atelier scientifique régional, Mont Sainte-Anne, January 27, 2002; Protagoniste à un débat à la Société canadienne de cardiologie, congrès 2001 à Halifax (22 octobre) au Symposium Satellite: La prise en charge des patients présentant un risque accru d'événements cardiovasculaires: les véritables débats. Sujet: Devrions-nous être plus sélectifs lorsque nous prescrivons des "pilules" éprouvées pour la prévention secondaire? Président d’un colloque ('La prescription d'exercice: considérations spéciales') au 2e Symposium international de Québec sur la réadaptation cardio-respiratoire 6-8 juin, 2001 Presentation à l’Atelier régional scientifique de l’Association des cardiologues du Québec sur « Les inhibiteurs des récepteurs IIb/IIIa plaquettaires », le 20 septembre 2000 Invited speaker National Atherosclerosis Forum: Results of the Can-ADA substudy on endothelial function. Montréal ) 22-24 septembre, 2000 Invited speaker at the symposium "Acute Coronary Syndromes: Searching for Innovative Solutions" (HealthCare Communications - Schering Canada Inc.), Hockley Valley Resort (Ontario), May 12-14, 2000 Invited speaker at the Grand Rounds, Quebec Heart Institute: A case of Acute Coronary Syndrome. April 27, 2000 Presentation au professeur A. Murad, prix Nobel de la médecine, à l’Hôpital Laval 23 avril 2000. Inflammation et maladie coronarienne Présentation aux médecins de l'urgence de l'Hôpital Laval sur la thrombolyse dans l'infarctus aigu, le 31 mars, 2000 Conférencier pour l’étude Can-ADA et la sous-étude sur la fonction endothéliale lors du Canadian Atorvastatin Research Roundtable (CARR), New York, 11-13 février, 2000 Grand Rounds de l’Institut de cardiologie de Québec 22 septembre 1999, Un cas d’angine post-infarctus Présentation à la journée de la recherche, Faculté de médecine, Université Laval, 25 mai, 1999, L'adénosine est-elle le médiateur impliqué dans l'atténuation de l'ischémie myocardique observée après un exercice de réchauffement?


of 44

Présentation sur ‘Le retour au travail post-infarctus’ le 25 avril, 1998 à l’Université Laval aux omnipraticiens dans le cadre du 7ième Colloque annuel de médecine du travail et de l’environnement du CLSC Haute-Ville Présentation au personnel du centre de recherche de l’hôpital Laval sur l’interprétation de l’ECG, 7 décembre 1997 Présentation à St John’s, Terre Neuve au Memorial University, Grand Rounds de médecine, L’angine instable: nouvelles données sur la pathogénèse et la thérapeutique, 5 décembre 1997 Présentation à la réunion de recherche en cardiologie 22 octobre, 1997, Nouvelles données: une dichotomie entre la maladie coronarienne aigue et la maladie coronarienne chronique Président d’une séance à la 4ième Conférence internationale de cardiologie préventive, Montréal, 30 juin, 1997, L’approche clinique du patient avec cardiopathie ischémique ou accident vasculaire cérébral Conférence conjointe de médecine de l’hôpital Laval, Nouveautés en réanimation cardio-respiratoires: nouveaux algorithmes d’intervention, 14 janvier, 1997 Présentation au personnel du centre de recherche a l’hôpital Laval, La cardiopathie ischémique les 19 et 26 novembre, 1996 Présentation au congrès de l’Association québécoise des infirmières et infirmiers en recherche clinique. Le rôle des plaquettes et de la coagulation dans les syndromes coronariens aigus, 18 octobre 1996 Accueil du Dr Lance Gould et du Dr Fréderic Sax pour présentations à la Société de cardiologie de Québec et à la réunion de recherche de l’Institut de cardiologie de Québec, 23-24 septembre et 30 septembre-1er octobre, 1996 Invited speadker at the Grand Rounds of the Jewish General Hospital, Montreal, April 29, 1996. Unstable Angina: Update and Overview” Invited speaker at the research ground rounds of the Quebec Heart Institute, L’unité coronarienne informatisée, March 20, 1996 President of a symposium, Le continuum de l’angine: nouvelles perspectives sur les mécanismes sous-jacents, Quebec (Château Frontenac), November 24-26, 1995 Invited speaker for the family physicians: La maladie coronarienne: concepts et prévention. Beaupré, Quebec June 13,1995 Invited speaker for the "clinician point of view" at, Méga-études symposium, recommandations provinciales et pharmaco-économie: leur impact sur la pratique médicale at the Ritz Carlton, Montreal, June 9,1995 Invited speaker at the Quebec cardiologist association convention de l'Association, debate protagonist-antagonist, Le meilleur traitement de l'angine instable: pharmacologique vs mécanique, Chicoutimi. Quebec June 1, 1995 Invited speaker at a panel-discussion, Angina Continuum Roundtable Meeting (Healthlink Communications) at the American College of Cardiology session meeting. New-Orleans, March 18, 1995


of 44

Invited speaker at the Royal Victoria Hospital: Cardiology Research Rounds, Stratification de risque post syndrome coronarien aigu: nouvelles perspectives et proposition pour une étude clinique. Montreal, January 23, 1995 Invited speaker at the cardiology department of Hôtel Dieu de Lévis , Quebec: presentation of the DOMASCA Study. December 10. 1994 Invited speaker at the medicine interdepartmental meeting, Hôpital St-François d’Assise: Les béta-bloqueurs post-infarctus. Quebec April 3, 1994 Invited speaker at the emergency department of Laval Hospital: Introduction to the GUSTO II Study. March 25, 1994 Invited speaker at the cardiology department of Hôpital de l’Enfant-Jésus, Quebec: presentation of the DOMASCA Study. March 9,1994 Invited speaker at the Grand Rounds’, Hôpital St-François d’Assise, Quebec on thrombolysis. March 2, 1994


of 44

RESEARCH GRANTS

Gene-Environment Interactions in Acute Coronary Syndrome. Principal investigator: Dr James Engert, Co-applicants: Bogaty, P, Brophy JM, Pilote L, Thanassoulis G. CIHR Project Scheme 2016 application Genetic Risk Scores for Acute Coronary SyndromeRisk Scores for Acute Coronary Syndrome. Principal investigator: Dr James Engert, Co-applicants: Bogaty, P, Brophy JM, Pilote L, Thanassoulis G. CIHR¹s Transitional Operating Grant (T-OOGP) 2015; Year 1: $72,784; Year 2: $207,363; Year 3: $113,103, submitted March 2015 INESSS, Unité de cardiologie: Le plan quinquénal de l’Unité de cardiologie de l’INESSS pour 2013-2018 est accepté en principe par le MSSS (oralement) mais pas officiellement encore (environ $1 million par année essentiellement pour mener à bien plusieurs évaluations-terrain (infarctus avec elevation ST-‘ETIAMEST-3’; valves percuamées aortiques; dispoistifs d’assistance ventriculaire ou ‘coeur mécanique’; pontage aorto-coronariens et angioplasties coronariennes à multiples vaiusseaux; accidents cérébraux vasculaires ischémiques). Dr Bogaty est le conseiller médical scientifique de l’Unité de cardiologie de l’INESSS. Development of a Genetic Risk Score to Predict Adverse Outcomes After an Acute Coronary Syndrome. Principal Investigator(s): THANASSOULIS, George Co-Investigators: BOGATY, Peter; BROPHY, James M; ENGERT, James C; PILOTE, Louise. - Operating Grant Competition(Year/Month): 2011/09 Assigned Peer Review Committee: CID Clinical Investigation - D Primary Institute: Population and Public Health Primary Theme: Social/Cultural/Environmental/Population Health Term (Yrs/Mths): Sept 15, 2011 for 2 yrs 0 mth $161670 AETMIS/Santé et Services Sociaux Québec, Octroi pour le Plan de 5 ans –evaluation en cardiologie tertiaire, Laurie Lambert PhD, Peter Bogaty MD, 09-2008-09-2013, $300 000 Ministère de la santé et des services sociaux, octroi, Évaluation-terrain de l'infarctus du myocarde avec élévation ST -2 (ETIAMEST-2), Laurie Lambert, Peter Bogaty Jean Morin, 09-2009-08-2014, environ $330 000 par année Investigation of Fluctuations in Inflammatory Markers in Stable Subjects Across the Clinical Spectrum of Ischemic Heart Disease Canadian – Operating Grant from the Canadian Institutes of Health Research (CIHR 2004). Principal applicant: Peter Bogaty; co-applicants: James Brophy, Janos Filep, Lawrence Joseph, Gilles R Dagenais ($240 342) 2006-2010. Effect Modfication of Gene-Mediated Susceptibility to Myocardial Infarction by Sex and Other Conventional Coronary Risk Factors – Principales initiatives stratégiques – Canadian Institutes of Health Research (CIHR). Principal Appliquant: Louise Pilote, Igor Karp; co-appliquants: Peter Bogaty, James Brophy, James Engert ($100 000) 2008-2010

Identification of Genetic Polymorphisms as a Predictor of Myocardial Infarction upon use of selective Cox-2 inhibitors. Appliquant principal: Dr JM Brophy, co-appliquant: C St. Germain, J Engert , P Bogaty. MUHC Pilot Project Competition.$20,000 November 2006 Toward Canadian Benchmarks for Health Services Wait times – Evidence, Application and Research Priorities II : Research Syntheses – Canadian Institutes of Health Research Strategic RFA (CIHR March 2006); Principal applicant: Tanya Armour; co-applicants: Dr Peter Bogaty, Dr George Well, Dr Ross Davies, Dr Jack Tu, Dr David Moher, Gregory Hirsch, Dr Blair O'Neill, Dr Kevin Glasgow, Dr Robert Gow ($92 974) 2006


of 44

Evaluation of a Novel Multi-Marker Approach (CRP and P-Selectin) to Risk Stratification in Acute Coronary Syndromes – Grant-in-aid to the Heart & Stroke Foundation of Canada ; Principal applicant: Peter Bogaty; co-applicant: Dr James Brophy, ($39 000) 2005-2008 Unrestrictive Grant Request to Pfizer Canada Independent Cardiovascular Research: Evaluation of a Novel Multi-Marker Approach (CRP and P-Selectin) to Risk Stratification in Acute Coronary Syndromes ($85 453) November 2005 Heart and Stroke Foundation Research Funding: Evaluation of Markers of Inflammation and P-selectin in Acute Coronary Syndromes. ($31 000) 2002-2004 Fonds de Recherche en Santé du Québec, Réseau cardio-vasculaire : Evaluation of Markers of Inflammation and P-selectin in Acute Coronary Syndromes. ($78 000) 2003 Fonds de Recherche en Santé du Québec, Réseau cardio-vasculaire: Investigation of C-Reactive Protein and Tumor Necrosis Factor Alpha as Markers of Persistent / Recurrent Instability in the Acute Coronary Syndromes (Étude RISCA). ($100 000) 2002 Canada Foundation for Innovation (CFI), (‘Réseau québécois d’études multicentriques en cardiologie’) (Multicenter project; ICM-U de M, Quebec Heart Institute/Laval University, McGill-Cardiology, CHUS-Cardiology. ($2 795 930) 2002 RISCA Study (Recurrence and Inflammation in Acute Coronary Syndromes) unrestricted grant Hoffman-La Roche Ltd, Canada. ($34 364) 2000 Can-ADA Substudy (Effect of Atorvastatin on Endothelial Function and on Exercise Ischemic Threshold) unrestricted grant Pfizer Canada Inc. ($24 380) 2001-2002 Principal Investigator for The Canadian Atorvastatin Trial (Can-ADA) Parke-Davis Canada. ($50 000) 1998-2001 RISCA Study (Recurrence and Inflammation in Acute Coronary Syndromes) unrestricted grant Merck Frosst Canada Inc. ($18 000) Sept 2000 Can-ADA Substudy (Effect of Atorvastatin on Endothelial Function and on Exercise Ischemic Threshold) unrestricted grant; Parke-Davis Canada. ($7 500) 1998-2000 Laval Hospital Foundation Pilot Study, (Short Hospital Stay in Low-Risk Myocardial Infarction) ($10 000) 1997


of 44

PUBLICATIONS IN MEDICAL JOURNALS

1. Bogaty P, Brophy JM. STEMI Treatment 2016: Is outcome improvement stalling and if so,

why? Can J Cardiol 2016;32:1193-1199.

2. Lambert LJ, Brophy JM, Racine N, Rinfret S, L’Allier PL, Brown KA, Boothroyd LJ, Ross D, Segal E, Kouz S, Maire S, Harvey R, Kezouh A, Nasmith J, Bogaty P. Outcomes of patients with ST-Elevation myocardial infarction receiving and not receiving reperfusion therapy: The importance of examining all patients. Can J Cardiol 2016;32:1325.e11-1325.e18

3. Bogaty P, L’Allier PL, Segal E, Rinfret S, Racine N, Harvey R, Ross D, Maire S, Kouz S,

Carroll C, Boothroyd LJ, Kezouh A, Azzi L, Brown KA, Nasmith J, Lambert LJ. Clinical Profiles Related to Timing of Death, Including In-Hospital Deaths Before Admission, in Patients With ST-Elevation Myocardial Infarction. Am J Cardiol 2016;117:347-52.

4. Labos C, Martinez SC, Wang L, Lenzini PA, Pilote L, Bogaty P, Brophy JM, Engert JC, Cresci S, Thanassoulis G. Utility of a genetic risk score to predict recurrent cardiovascular event 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohorts. Atherosclerosis 2015;242:261-7.

5. Boothroyd LJ, Lambert LJ, Segal E, Ross D, Kouz S, Maire S, Harvey R, Xiao Y, Brown KA, Nasmith J, Bogaty P. Comparison of Outcomes of Ambulance Users and Non-users in ST-Elevation Myocardial Infarction. Am J Cardiol 2014;114:1289-94.

6. Brown KA, Lambert LJ, Brophy JM, Nasmith J, Rinfret S, Segal E, Kouz S, Ross D, Harvey R, Maire S, Boothroyd LJ, Bogaty P. Impact of ECG findings and process-of-care characteristics on the likelihood of not receiving reperfusion therapy in patients with ST-elevation myocardial infarction: Results of a field evaluation. PLOS ONE 2014;9:e104874.

7. Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau E, Carrier M, Cecere R, Morin JE, Bogaty P. Challenge of informing patient decision making: What can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues? Circ Cardiovasc Qual Outcomes 2014;7:179-87.

8. Cardinal H, Madore F, Brophy JM, Joseph L, Hébert MJ, Min S, Boyer L, Bogaty P.

Longitudinal trends in sFas, a biomarker of apoptosis, after an acute coronary syndrome: Clues to the pathogenesis underlying adverse events on follow-up. Int J Cardiol 2014;173(3):603-7.

9. Labos C, Wang RH, Pilote L, Bogaty P, Brophy JM, Engert JC, Thanassoulis G. Traditional

risk factors and a Genetic Risk Score are associated with age of first acute coronary syndrome. Heart 2014 May 29 [Epub ahead of print].

10. Lambert LJ, Brown KA, Boothroyd LJ, Segal E, Maire S, Kouz S, Ross D, Harvey R, Rinfret

S, Xiao Y, Nasmith J, Bogaty P. Transfer of patients with ST-elevation myocardial infarction for primary percutaneous coronary intervention: A province-wide evaluation of "door-in to door-out" delays at the first hospital. Circulation 2014;129:2653-60.

11. Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau É, Carrier M,

Cecere R, Morin JE, Bogaty P. Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues? Circ Cardiovasc Qual Outcomes 2014;7:179-87.

12. Bogaty P, Lambert L, Brophy JM. Door-to-balloon time and mortality. N Engl J Med

2014;370:178.


of 44

13. Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau E, Carrier M,

Cecere R, Morin JE, Bogaty P. Should eligibility for heart transplantation be a requirement for left ventricular assist device (LVAD) use? Recommendations based on a systematic review. Can J Cardiol 2013;29:1712-20.

14. Bogaty P, Brophy JM. Fibrinolysis or primary PCI in myocardial infarction. N Engl J Med 2013 Jul 18;369(3):279; discussion page 281..

15. Bogaty P, Dagenais GR, Joseph L, Boyer L, Leblanc A, Bélisle P, Brophy JM. Time Variability of C-Reactive Protein: Implications for Clinical Risk Stratification. PLoS ONE 2013;8:e60759 http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060759

16. Dagenais GR, Lu J, Faxon DP, Bogaty P, Adler D, Fuentes F, Escobedo J, Krisnaswami A, Slater J, Frye RL. Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Stable Coronary Artery Disease Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Am Coll Cardiol 2013;61:702-11.

17. Boothroyd LJ, Segal E, Bogaty P, Nasmith J, Eisenberg MJ, Boivin JF, Vadeboncœur A,

Champlain FD. Information on Myocardial Ischemia and Arrhythmias Added by Prehospital Electrocardiograms. Prehosp Emerg Care 2013;17:187-192.

18. Boothroyd LJ, Spaziano M, Guertin JR, Lambert LJ, Rodés-Cabau J, Noiseux N, Nguyen M,

Dumont E, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty P. Transcatheter Aortic Valve Implantation: Recommendations for Practice Based on a Multidisciplinary Review including Cost-effectiveness, Ethical and Organizational Issues. Can J Cardiol 2013;29:718-726.

19. Lambert L, Blais C, Hamel D, Brown K, Rinfret S, Cartier M, Giguère M, Caroll C,

Beauchamp Christiane, Bogaty P. Evaluation of care and surveillance of cardiovascular disease: Can we trust medico-administrative hospital data? Can J Cardiol 2012;28:162-8. doi: 10.1016/j.cjca.2011.10.005. Epub 2012 Jan 9.

20. Bogaty P, Filion K, Brophy JM. Routine Invasive Management After Fibrinolysis in Patients with ST-Elevation Myocardial Infarction: A Critical Review. BMC Cardiovasc Disord. 2011;11:34.

21. Hamelin BA, Zakrzewski-Jakubiak M, Robitaille MN, Bogaty P, Labbé L, Turgeon J.

Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent. J Clin Pharmacol 2011; 51:1286-92.

22. St Germain CG, Bogaty P, Boyer L, Hanley J, Engert JC, Brophy JM. Genetic

polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs. Am J Cardiol 2010;105:1740-5.

23. Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA 2010;303:2148-55.

24. Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert MJ, Boyer L, Madore F. Usefulness of Fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes. Am J Cardiol 2010; 105:797-803.

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0060759


of 44

25. Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Comparison of Myocardial Ischemia on the Ergocycle versus the treadmill in patients with coronary heart disease. Am J Cardiol 2010; 105:633-9.

26. Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy JM. Therapeutic Management in Patients with Renal Failure who Experience an Acute Coronary Syndrome. Clin J Am Soc Nephrol 2009;5:87-94.

27. Bogaty P, Brophy JM. Letter to the Editor in response to Cantor WJ et al. Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. N Eng J Med 2009;361:1508.

28. Bogaty P. Duration of Symptoms Is Not Always the Key Modulator of the Choice of

Reperfusion for ST-Elevation Myocardial Infarction. Circulation 2009;119:1304-10.

29. Bogaty P. Response to Armstrong P et al. Duration of Symptoms Is the Key Modulator of the Choice of Reperfusion for Myocardial Infarction. Circulation 2009;119:1303.

30. Ferland A, Brassard P, Lemieux S, Bergeron J, Bogaty P, Bertrand F, Simard S, Poirier P.

Impact of High-fat/low-carbohydrate, High-, Low-glycaemic Index or low-caloric Meals on Glucoregulation during Aerobic Exercise in Type 2 Diabetes. Diabet Med 2009;26:589-95.

31. Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Després JP, Bernard PM, Bogaty P.

Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. CMAJ 2009;180:40-7.

32. Bogaty P. Little predictive value in measuring CRP levels in ACS patients, new study

suggests. 9 Juin 2008 http://www.theheart.org/article/873105.do Heart Org 2008 33. Rodés-Cabau J, Noël M, Marrero A, Rivest D, Mackey A, Houde C, Bédard E, Larose E,

Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF. Atherosclerotic Burden findings in young cryptogenic stroke patiens with and without foramen ovale. Stroke 2008;40:419-25. Epub 2008 Dec 18.

34. Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F,

Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008;118:2326-9. Epub 2008 Nov 24.

35. Bogaty P, Simard S, Dagenais GR, Brophy JM. Acute Coronary Syndromes: “To CRP or not

to CRP?" J Am Coll Cardiol 2008;52:1500; author reply 1500-1. 36. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Roux R, d'Astous M,

Bertrand F, Dagenais GR, Brophy J. Clinical utility of C-reactive protein measured at admission, hospital discharge or one month later to predict outcome in patients with acute coronary disease: The RISCA Study. J Am Coll Cardiol 2008;51:2339-46.

37. Bogaty P, Poirier P, Boyer L, Simard S, Morin J, Dagenais GR. Effects of Exogenous

Metabolic Substrate Modulation on Exercise-Induced Myocardial Ischemia. Am Heart J 2008;156:790-796. Epub 2008 Aug 9.766

38. Bogaty P , Brophy JM. Letter to the editor in response to Citywide Protocol for Primary PCI

in ST-Segment Elevation Myocardial Infarction, Le May et al. N Eng J Med 2008;358:1751.

http://www.onlinejacc.org/content/51/24/2339


of 44

39. Bogaty P, Noël M. Poirier P, Dagenais R. Can prolonged exercise-induced myocardial ischaemia be innocuous? reply. Eur Heart J. 2008;29:139-40.

40. Bogaty P, Boothroyd L, Lambert L, Lance JM, Paquette D. Enjeux organisationnels

préhospitaliers, intra et interhospitaliers et économiques pour la prise en charge avec l'infarctus aigu du myocarde avec élévation du segment ST (IAMEST). Agence d'évaluations des technologies et des modes d'intervention en santé 2007. http://www.aetmis.gouv.qc.ca/site/34.1064.0.0.1.0.phtml

41. Lambert L, Bogaty P, Brophy J, Boothroyd L. La pratique d'interventions coronariennes

percutanées dans les hôpitaux sans service de chirurgie cardiaque sur place: revue des lignes directrices et analyse des donnée québecoises de 1999-2004. Agence d'évaluations des technologies et des modes d'intervention en santé 2007. http://www.aetmis.gouv.qc.ca/site/phpwcms_filestorage/c50a9b653ab55beeda8d2f11a01285c6.pdf

42. Bogaty P, Noël M, Poirier P, Dagenais GR. Can prolonged exercise-induced myocardial

ischaemia be innocuous? Author reply. Eur Heart J 2007;29:139-40. 43. Dagenais G, Philippon F, Després JP, Dumesnil JG, Cartier P, Bogaty P, Lemieux M,

Moisan A. The Quebec Heart Institute: 50 years of excellence in cardiology. Can J Cardiol 2007;23:Suppl B:5B-8B.

44. Brassard P, Legault S, Garneau C, Bogaty P, Dumesnil JG, Poirier P. Normalization of

diastolic dysfunction in type 2 diabetics after exercise training. Med Sci Sports Exerc 2007;39:1896-901.

45. Noël M, Jobin J, Marcoux A, Poirier P, Dagenais GR, Bogaty P. Can Prolonged Exercise-

Induced Myocardial Ischemia Be Innocuous? Eur Heart J ;28:1559-65. 46. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe

aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer prognosis: implications for diagnosis and treatment. Circulation 2007;115:2856-64.

47. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Effect of a ramp versus standard Bruce

exercise test protocol on exercise-induces myocardial ischemia. Am J Cardiol 2007;99:921-4.

48. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, Leong-Poi H,

Miller RM, Nichol G, Freeman, Bogaty P, Honos G, Hudon G. Wisenberg G, Van Berkom J, Williams K, Yoshinaga K, Graham ; on behalf of the Canadian Cardiovascular Society, the Canadian Association of Radiologist, the Canadian association of Nuclear Medicine, The Canadian Nuclear Cardiology Society and the Canadian Society of Cardiac Magnetic Resonance. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. Can J Cardiol2007;23:107-119.

49. Bogaty P, Brophy JM. Acute ischemic heart disease and interventional cardiology: A time for

a pause. BMC Medicine 2006 ;4 :25. 50. Brassard P, Ferland A, Bogaty P, Desmeules M, Jobin J and Poirier P: Influence of glycemic

control on pulmonary function and heart rate in response to exercise in subjects with type 2 diabetes mellitus Metabolism 2006 ;55:1532-37.

https://www.inesss.qc.ca/nc/publications/publications/publication/infarctus-aigu-du-myocarde-avec-elevation-du-segment-st-iamest-enjeux-organisationnels-et-eco.html

https://www.inesss.qc.ca/fileadmin/doc/AETMIS/Rapports/Cardiologie/ETMIS2007_Vol3_No9.pdf


of 44

51. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S and Poirier P: The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women. Menopause 2006;13:959-66.

52. Bourgault C, Bergeron S, Bogaty P, Poirier P. A most unusual acute coronary syndrome.

Can J Cardiol 2006;22:1-4. 53. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. ACE-DD genotype is

associated with the occurrence of acute coronary syndrome in postmenopausal women. Int J Cardiol 2005;105:308-14.

54. Armstrong PW, Bogaty P, Buller CE, O’neill BJ. Guidelines for STEMI. CMAJ

2005;172:1426. 55. Bogaty P, Brophy JM. Numbers needed to treat (needlessly?). Lancet 2005;365: 1307-08. 56. Bogaty P, Brophy J. GRACIA : Implications for clinical practice. Lancet 2005;365:381. 57. Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Dagenais GR. Fluctuating inflammatory

markers in patients with stable ischemic heart disease. Arch Int Med 2005 ;165 :221-226. 58. Methot J, Hamelin B, Bogaty P, Arsenault M, Plante S, Poirier P. Does hormonal status

influence the clinical presentation of acute coronary syndromes in women? J Womens Health 2004;13:695-702.

59. Bogaty P, Buller CE, Dorian P, O’Neill BJ, Armstrong PW. Reperfusion in acute ST elevation

myocardial infarction : Application of new ST-elevation myocardial infarction (STEMI) guidelines. CMAJ 2004 ;171 :1039-1041.

60. Dorian P, Bogaty P, Buller CE, O ‘Neill BJ, Armstrong PW. Disturbances of cardiac rhythm

after ST-elevation myocardial infarction : Application of new ST-elevation myocardial infarction (STEMI) guidelines. CMAJ 2004 ;171 :1042-44.

61. Brophy JM, Bogaty P. Primary angioplasty and thrombolysis are both reasonable options in

acute myocardial infarction. Ann Int Med 2004;141:292-297. 62. Bogaty P, Brophy J, Boyer L, Simard S, Bertrand F, Noel M, Dagenais GR. Impact of

prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study. Circulation 2004;110:934-939.

63. Armstrong P, Bogaty P, Buller C, Dorian P, O'Neill B. The 2004 ACC/AHA Guidelines: A

Perspective and Adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol 2004;20:1075-1079.

64. Bogaty P, Brophy J. Primary angioplasty or thrombolysis? A topical parable. BMJ

2004;328:1257-1258. 65. Fitchett D, Rockwood K, Chan BT, Schultz S, Bogaty P, Gillis A, Arnold M, Miller F, Graham

MM, Ghali WA, Cartier R. Chow CM, Grymonpre R, Ogilvie R, Rochon P, Niznick J, Grover S, Kavanah T, Triscott J, Dafoe W, McCartney N, Rodney P, Howlett J, Chockalingam A, Dagenais G, Dalziel W, Fodor G, Goodman S, Kerr C, Power B. Murphy K. Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol 2004;20(suppl A):7A-16A.


of 44

66. Bogaty P, Dagenais GR, Poirier P, Boyer L, Auclair L, Pépin G, Jobin J, Arsenault M. Effect of Atorvastatin on exercise-induced myocardial ischemia in patients with stable angina pectoris. Am J Cardiol 2003;92:1192-1195.

67. Bogaty P, Brophy J. Increasing burden of treatment in the acute coronary syndromes : Is it

justified? Lancet 2003;361:1813-1816. 68. Dagenais GR, Auger P, Bogaty P, Gerstein H, Lonn E, Yi Q, Yusuf S; HOPE Study

Investigators.Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity. Can J Cardiol. 2003;19:1387-1391.

69. Bogaty P, Poirier P, Dagenais GR, Boyer L, Jobin J. What induces warm-up ischemia /

Angina Phenomenon: exercise or myocardial ischemia? Circulation 2003;107:1858-1863. 70. Hamelin BA, Methot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P. Influence of the

menstrual cycle on the timing of acute coronary events in young women with coronary artery disease. Am J Med 2003;114:599-602.

71. Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG. Preclinical diabetic

cardiomyopathy : Relation of left ventricular diastolic dysfunction to cardiac automatic neuropathy in uncomplicated well-controlled men with type 2 diabetes. Metabolism 2003;52:1056-1061.

72. Morin J, Bogaty PM, Roy L, Poirier P. Trauma-induced occlusion of the left anterior

descending artery following a snowmobile accident in a man without prior coronary artery disease. Can J Cardiol 2003;5:565-568.

73. Bogaty P, Boyer L, Rousseau L, Arsenault M. Is anteroseptal myocardial infarction an

appropriate term? Am J Med 2002;113:37-41. 74. Bogaty P, Muré P, Dumesnil JG. New Insights into Diastolic Dysfunction as the Cause of

Acute Left-Sided Heart Failure Associated With Systemic Hypertension and/or Coronary Artery Disease. Am J Cardiol 2002;89:341-345.

75. Cantin B, Despres JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais

GR. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am J Cardiol 2002;89:662-666.

76. Bergeron S, Demers C, Bogaty P, Poirier P. The endocarditis that was not: an unsual case

of heparin-induced thrombocytopenia with unusual complications. Can J Cardiol 2001;17:1180-1182.

77. Huynh T, Théroux P, Bogaty P, Nasmith J, Solymoss S. Aspirin, warfarin or the combination

for the secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 2001;103:3069-3074.

78. Bogaty P, Poirier P, Simard S, Solymoss S, Boyer L, Dagenais GR. Biological profiles in

subjects with recurrent acute coronary events compared to longstanding stable angina Circulation 2001;103:3062-3068.

79. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, Bergeron J, Després,

J-P. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-967.

80. Bogaty P. Myocardial Infarction After Dog Bite. Circulation 2001;103:e95-a. 81. Porier P, Bogaty P, Garneau C, Marois L, Dumesnil J-G. Diastolic dysfunction in

normotensive men with well-controlled type 2 diabetes. Diabetes Care 2001;24:5-10.


of 44

82. Bogaty P, Dumont S, O'Hara GE, Boyer L, Auclair L, Jobin J, Boudreault JR. Randomized

trial of a non-invasive strategy to reduce hospital stay for patients with low-risk myocardial infarction. J Am Coll Cardiol 2001;37:1289-1296.

83. Bogaty P, Kingma J, Guimond J, Poirier P, Boyer L, Charbonneau L, Dagenais GR.

Myocardial perfusion imaging findings and the role of adenosine in the warm-up angina phenomenon. J Am Coll Cardiol 2001;37:463-469.

84. Kingma JG Jr, Plante S, Bogaty P . Platelet GPIIb/IIIa blockade reduces infarct size in a

canine model of ischemia-reperfusion. J Am Coll Cardiol 2000;36:2317-2324. 85. Poirier P, Garneau C, Bogaty P, Nadeau A, Marois L, Brochu C, Gingras C, Fortin C, Jobin

J, Dumsenil J-G. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 2000;85:473-477.

86. Bogaty P, Dagenais GR. Revascularization after myocardial infarction. Circulation

1999;99:1272-1273. 87. Bogaty P, Kingma JG, Robitaille N-M, Plante S, Simard S, Charbonneau L, Dumesnil JG.

Attenuation of myocardial ischemia with repeated exercise in subjects with chronic stable angina: relation to myocardial contractility, intensity of exercise, and the ATP-sensitive potassium channel. J Am Coll Cardiol 1998;32:1665-1671.

88. Bogaty P, Robitaille N-M, Solymoss S, Boyer L, Auger D, Labbé L, Simard S, Rail J, Genest

Jr J, Turgeon J. Atherogenic, hemostatic and other potential risk markers in subjects with previous isolated myocardial infarction compared to longstanding uncomplicated stable angina. Am Heart J 1998;136:884-893.

89. Tanser P, Baird M, Bogaty P, Bernstein V, Cox J, Cujec B, Finnie K, Langer A, McCans J,

McKelvie R, Miller A, Parker JO, Rose B, Sestier F, Warnica W. Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and Management of Chronic Ischemic Heart Disease. Can J Cardiol 1998;14 (Suppl C):1C-24C.

90. Brophy JM, Diodati JG, Bogaty P, Théroux P. The delay to thrombolysis: An analysis of

patient and hospital characteristics. CMAJ 1998;158:475-480. 91. Cairns J, Théroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable

angina: report from a Canadian Expert Roundtable. Can J Cardiol 1996;12:1279-92 (also appears in ACC Current Journal Review July/August 1998 pp 43-8).

92. Miyagashima R, Plante S, Abel JG, Bogaty P. Unstable Angina and non-Q-wave infarction.

Can J Cardiol 1997;13 (suppl D):30D-39D. 93. Bogaty P, Guimond J, Robitaille N-M, Rousseau L, Simard S, Rouleau JR, Dagenais GR. A

reappraisal of exercise electrocardiographic indices of the severity of ischemic heart disease: angiographic and scintigraphic correlates. J Am Coll Cardiol 1997;29:1497-1504.

94. çKingma JG Jr, Bogaty P. Reperfusion injury: fact, fiction or simply unresolvable? J Thromb

Thrombolysis 1997;4:145-147. 95. Cairns J, Theroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable

Angina—report from a Canadian expert rountable. Can J Cardiol 1996;12:1279-1292.


of 44

96. Dagenais GR, Cantin B, Dagenais F, Lupien PJ, Robitaille N-M, Bogaty P. Importance of outside hospital mortality as a first acute ischemic heart event: The Quebec Cardiovascular Study. Can J Cardiol 1996;12:914-918.

97. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity at culprit lesions (Letters to the

Editor) Circulation 1995;91:563-564. 98. Bogaty P, Gavrielides S, Mure P, Gaspardone A, Maseri A. The duration and magnitude of

ST segment depression during exercise and recovery: A symmetrical relationship. Am Heart J 1995;12:666-671.

99. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable

angina. Circulation 1994;90:5-11. 100. Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. A

comparison of coronary angiographic findings at acute and chronic first presentation of ischemic heart disease. Circulation 1993;87:1938-1946.

101. Tousoulis D, Kaski JC, Bogaty P, Crea F, Gavrielides S, Galassi A, Maseri A. Reactivity of

proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina. Am J Cardiol 1991; 67:1195-200.

102. Dagenais GR, Rouleau JR, Bogaty P. Prognosis for patients with painless strongly positive

exercise ECGs. J Angina Silent Ischemia 1990; 5:4-7. 103. Bogaty P, Dagenais GR, Cantin B, Alain P, Rouleau JR. Prognosis in patients with a

strongly positive exercise electrocardiogram. Am J Cardiol 1989;64:1284-8. 104. Bogaty P, Waters DD. Circadian patterns in coronary disease: the mournefulness of

morning. Can J Cardiol 1988;4:5-11.

PUBLISHED BOOK CHAPTERS

1. Brophy JM, Bogaty P, Hot Topic: Cyclooxygenase-2 inhibition and coronary risk.

Harrisons’online updates http://www.accessmedicine.com 2005 Related To: Chapter 225. Prevention and Treatment of Atherosclerosis; Chapter 226. Ischemic Heart Disease; Chapter 312. Osteoarthritis.

2. Dagenais GR, Bogaty P. Impacts of ACE inhibitors on diseases of the heart, kidneys, and

brain. In Drug Advances, Jean Gray, ed., REMEDICA Publishing Ltd (London, UK) 2003, Chapter 5, pp. 113-135.

3. Bogaty P, Waters DD. Circadian patterns in heart disease. Chronopharmacology: Cellular

and Biochemical Interactions, edit. Bjorn Lemmer. Marcel Dekker Inc., New York and Basel 1989. Chapter 22, pp 509-24.


of 44

ABSTRACTS - - CARDIOLOGY CONVENTIONS

1. Lambert LJ, Azzi L, Asgar A, Potter B, Lamarche Y, de Varennes B, Noiseux N, Cartin M,

Daneault B, Généreux P, Martucci P, Racine N, Ibrahim R, Sas G, Bogaty P. Evaluation of transcatheter aortic valve implantation in Quebec using newly-established Canadian cardiovascular society quality indicators. Can J Cardiol 2016;32:S101.

2. Lambert LJ, Azzi L, Harvey R, Kouz S, Maire S, Racine N, Rinfret S, Ross D, segal E, Déry J, L’allier Pm Boothroyd L, Carroll C, Beauchamp C, Bogaty P. A comparison of quality of care of patients with ST-Elevation myocardial infarction by choice of reperfusion strategy: Results of a Quebec-wide systematic field evaluation (2013-2014). Can J Cardiol 2016;32:S205.

3. Lambert LJ, Ducharme A, Azzi L, Sas G, Charbonneau E, Cecere R, Gauthier M, Giannetti

N, Racine N, Stanbridge D, Bourgault C, Carrier M, Afilalo J, Sanscartier C, Bogaty P. Evolution in the use of long-term left ventriculare assist devices in Québec: 2010-12 versus 2013-15 and comparison with the Intermacs registry. Can J Cardiol 2016;32:S291.

4. Lambert LJ, Sas G, Azzi L, Ducharme A, Carrier M, Cecere R, Charbonneau E,

Sanscartier C, Morin JE, Bogaty P. Characteristics and clinical outcomes of patients with long-term ventricular assist devices in Quebec compared with the INTERMACS registry. Circulation: Cardiovascular Quality and OutcomesMay 2015; Vol. 8, No. Suppl 2 in press.

5. Lambert LJ, Azzi L, Harvey R, Kouz S, L'Allier PL, Maire S, Rinfret S, Ross D, Segal E,

Carroll C, Beauchamp C, Boothroyd LJ, Bogaty P. Treatment delays in patients with ST-elevation myocardial infarction across all hospitals performing primary percutaneous coronary intervention in Quebec, Canada: Results of a third field evaluation. Circulation: Cardiovascular Quality and OutcomesMay 2015; Vol. 8, No. Suppl 2 in press.

6. Lambert LJ, Sas, G, Azzi L, Carrier M, Daneault B, Dumont E, Généreux P, Ibrahim R,

Lamarche Y, Martucci G, Noiseux N, Rodès-Cabau J, de Varennes B, Morin JE, Bogaty P. How should we measure quality of care for transcatheter aortic valve implantation (TAVI)? Results for 6 Quebec TAVI programs compared with international registries. Circulation: Cardiovascular Quality and OutcomesMay 2015; Vol. 8, No. Suppl 2 in press.

7. Lambert LJ, Boothroyd LJ, Azzi L, Segal E, Ross D, Maire S, Harvey R, Racine N, Kouz S,

L’Allier PL, Rinfret S, Carroll C, Beauchamp C, Bogaty P. Primary angioplasty treatment delays after the implementation of a province-wide prehospital ECG program. Can J Cardiol 2015;31:S9.

8. Lambert LJ, Azzi L, Harvey R, Kouz S, L’Allier PL, Maire S, Racine N, Rinfret S, Ross D,

Segal E, Carroll C, Beauchamp C, Boothroyd LJ, Bogaty P. Treatment delays on hours versus off hours in patients with ST-Elevaltion infarction across all hospitals performing primary angioplasty in Québec, Canada: Results of a third field evaluation. Can J Cardiol 2015;31:S11.

9. Lambert LJ, Sas G, Azzi L, Daneault B, Généreux P, Noiseux N, Lamarche Y, Martucci G,

Ibrahim R, Benoit D, Dumont É, Rodés-Cabau J, Carrier M, Morin JE, Bogaty P. Use and outcomes of transcatheter aortic valve implantation: Results of a Quebec-wide field evaluation. Can J Cardiol 2015;31:S19.

http://circoutcomes.ahajournals.org/content/8/Suppl_2/A374

http://circoutcomes.ahajournals.org/content/8/Suppl_2/A213

http://circoutcomes.ahajournals.org/content/8/Suppl_2/A360?cited-by=yesl8%2FSuppl_2%2FA360


of 44

10. Lambert LJ, Sas G, Azzi L, Carrier M, Daneault B, Dumont É, Généreux P, Ibrahim R, Lamarche Y, Martucci G, Noiseux N, Rodés-Cabau J, De Varennes B, Morin JE, Bogaty P. What are the best indicators of the performance of transcatheter aortic valve implantation? Measures of quality in Québec compared with international registries. Can J Cardiol 2015;31:S23.

11. Guertin JR, Lambert LJ, Blais S, Robert N, Asgar A, Sas G, Lachapelle P, Tremblay V,

Azzi L, Sanscartier C, Morin JE, Bogaty P. Intra-hospital cost of implanting a transcatheter aortic valve: A Québec perspective. Can J Cardiol 2015;31:S115.

12. Lambert LJ, Sas G, Azzi L, Ducharme A, Carrier M, Cecere R, Charbonneau E,

Sanscartier C, Morin JE, Bogaty P. Can J Cardiol 2015;31:S139. 13. Ducharme A, Charbonneau E, Cecere R, Carrier M, Giannetti N, Sénéchal M, Lambert LJ,

Sas G, Sanscartier C, Azzi L, Bogaty P. Insights from a Québec field evaluation of left bentricular assist device therapy compared with the intermacs registry: Can small still be beautiful? Can J Cardiol 2015;31:S200.

14. 15. Lambert LJ, Sas G, Dragieva N, Reeves F. Langlois Y, Nguyen M, Bilodeau L, Voisine P,

Carrier M, Pellerin M, Morin JE, Brown K, Bogaty P. What kinds of patients with coronary artery disease are treated with multivessel percutaneous intervention versus bypass surgery? A province-wide field evaluation in Quebec hospitals with on-site cardiac surgery. Can J Cardiol 2014;30:S259.

16. Garcia-Labbé D, Dagenais GR, Simard S, LeBlanc A, Boyer L, Bogaty PM. High-Sensitivity cardiac troponin T detections and fluctuations over a year in patients with stable coronary artery disease: Is the clinical history important? Can J Cardiol 2014;30:S339.

17. Labos C, Wang R, Pilote L, Bogaty P, Brophy JM, Engert JC, Thanassoulis G. Utility of LDL Cholesterol genetic risk score to predict recurrent cardiovascular events after acute coronary syndrome. Can J Cardiol 2014;30:S118.

18. Lambert LJ, Sas G, Dragieva N, Reeves F, Nguyen M, Bilodeau L, Langlois Y, Voisine P,

Carrier M, Pellerin M, Morin JE, Brown KA, Bogaty P. Characteristics of patients with coronary artery disease treated with multivessel percutaneous coronary intervention in hospitals with and without on-site cardiac surgery in Quebec: A province-wide field evaluation. Can J Cardiol 2014;30:S147-148.

19. Lambert LJ, Sas G, Dragieva N, Ducharme A, Carrier M, Cecere R, Charbonneau E, Boothroyd LJ, Sanscartier C, Morin JE, Bogaty P. The Quebec experience with long-term left ventricular assist devices: characteristics and outcomes compared with the Intermacs Registry. Can J Cardiol 2014;30:S241-242.

20. Lambert LJ, Sas G, Dragieva N, Daneault B, Généreux P, Noiseux N, Lamarche Y, Martucci G,

Ibrahim R, De Varennes B, Dumont E, Rodés-Cabau J, Carrier M, Spaziano M, Morin JE, Bogaty P. Use and outcomes of Transcatheter Aortic Valve Implantation : results of a Quebec-wide field evaluation and comparison with the TVT Registry. Can J Cardiol 2014;30:S244.

21. Guertin JR, Sas G, Robert N, Lambert L, Sanscartier C, Morin JE, Bogaty P. Intra-hospital

cost of implanting a left ventricular assistance device: A Canadian perspective. Value Health 2014;17(3):A112-3.

22. Lambert LJ, Dragieva N, Reeves F, Langlois Y, Nguyen M, Bilodeau L, et al.

Characteristics of patients with multivessel coronary disease treated with percutaneous intervention versus bypass surgery and preliminary mortality outcomes: A province-wide field evaluation. Circ Cardiovasc Qual Outcomes 2014;21(7 Suppl):A122.


of 44

23. Lambert LJ, Sas G, Dragieva N, Boothroyd LJ, Ducharme A, Carrier M, et al. Characteristics and 1-year outcomes of patients with long-term left ventricular assist devices (LVAD) in Quebec compared with the INTERMACS registry. Circ Cardiovasc Qual Outcomes 2014;21(7 Suppl):A217.

24. Lambert LJ, Sas G, Dragieva N, Daneault B, Généreux P, Noiseux N, et al. Results of a

province-wide field evaluation of the use and outcomes of transcatheter aortic valve implantation (TAVI) in Quebec compared with the STS/ACC registry. Circ Cardiovasc Qual Outcomes 2014;21(7 Suppl):A364.

25. Boothroyd L, Xiao Y, Lambert L, Segal E, Ross D, Maire S, Bogaty P. Ambulance use versus nonuse in patients with ST-segment elevation myocardial infarction: A powerful prognosticator of mortality risk. Prehosp Emerg Care 2013;17(1):119.

26. Brown K, Segal E, Lambert L, Carroll C, Ross D, Maire S, Boothroyd L, Bogaty P. Transfer

of patients with ST-segment elevation myocardial infarction for primary percutaneous coronary intervention (primary PCI): Identifying sources of delay in the first hospital center. Prehosp Emerg Care 2013;17(1):119.

27. Boothroyd L, Xiao Y, Lambert L, Segal E, Ross D, Maire S, Bogaty P. Initial impact of prehospital electrocardiograms acquired by basic life support paramedics on processes of care in patients with ST-segment elevation myocardial infarction: A provincewide evaluation. Prehosp Emerg Care 2013;17(1):128.

28. Dagenais GR, Lu J, Faxon DP, Bogaty P, Adler D, Fuentes F, Escobedo J, Krishnaswami

A, Slater J, Frye RL. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: Results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. J Am Coll Cardiol 2013;61(7):702-11.

29. Labos C, Engert JC, Wang RH, Bogaty P, Brophy J, Thanassoulis GC. Use of a genetic

risk score to predict adverse outcomes after ACS. Circulation 2013;128(22 Suppl 1):A16726.

30. Labos G, Engert JC, Wang R, Bogaty P, Brophy J, Thanassoulis G. Development of a

genetic risk score to predict adverse outcomes after ACS. Can J Cardiol 2013;29 (Suppl);S292.

31. Sas G, Xiao Y, Lambert LJ, Ducharme A, Carrier M, Cecere R, Charbonneau E, Sanscartier C, Morin JE, Bogaty P. Characteristics and outcomes of patients with long-term left ventricular assist devices in Quebec, 2011-2012. Can J Cardiol 2013;29 (Suppl);S109-100.

32. Lambert LJ, Y XiaoY, Carrier M, Langlois Y, Voisine P, Carroll C, Beauchamp C, Morin JE, Bogaty P. Characteristics and outcomes of patients who underwent multi-vessel coronary bypass surgery in Quebec, 2010-2012. Can J Cardiol 2013;29 (Suppl);S251.

33. Lambert LJ, Xiao Y, Sas S, Segal E, Kouz S, Harvey R, Ross D, Rinfret S, L’Allier PL,

Nasmith J, Bogaty P. A comparison of causes of short-term and long-term death among STEMI and NSTEMI patients: Results from a province-wide field evaluation. Can J Cardiol 2013;29 (Suppl);S299.

34. Lambert LJ, Clement L, Boothroyd, LJ Beauchamp C, Carroll C, Bogaty P. Time-critical

cardiovascular care in Quebec: Advantages of a novel collaborative initiative to improve outcomes for both acute myocardial infarction and ischemic stroke. Can J Cardiol 2013;29 (Suppl);S258.


of 44

35. Lambert LJ, Xiao Y, Kouz S, Rinfret S, Segal E, Ross D, L'Allier PL, Vanasse A, Maire S, Nasmith J, Bogaty P. Comparison of outcomes by type of treatment for patients with ST-elevation myocardial infarction (STEMI) who presented to hospitals without percutaneous coronary intervention (PCI) facilities in Quebec, Canada. Circ Cardiovasc Qual Outcomes 2013;6(3 Suppl 1):A82.

36. Lambert LJ, Xiao Y, Rinfret S, Kouz S, L'Allier PL, Segal E, Ross D, Vanasse A, Maire S,

Nasmith J, Bogaty P. Evaluation of 30-day mortality in patients with ST-elevation myocardial infarction (STEMI) across all hospital centers performing primary percutaneous coronary intervention (PPCI) in Quebec, Canada. Circ Cardiovasc Qual Outcomes 2013;6(3 Suppl 1):A175.

37. Sas J, Lambert LJ, Boothroyd LJ, Ducharme A, Charbonneau E, Carrier M, Cecere R, Guertin JR, Morin JE, Bogaty P. What Can The Patient With Chronic End-Stage Heart Failure Expect Fromm a Long-Term Left Ventricular Assist Device? A Systematic Review of Current Evidence. Can J Cardiol 2012;28(Suppl):S337-S338.

38. Bogaty P, Xiao Y, Rinfret S, L’Allier P, Segal E, Maire S, Kouz S, Ross D, Vanasse A, Nasmith J, Lambert LJ. Clinical Profiles Associated With Timing of Death in Patients With ST-Elevation Myocardial Infarction: Results of a Province-Wide Field Evaluation. Can J Cardiol 2012;28(Suppl):S377-S378.

39. Lambert LJ, Xiao Y, Rinfret S, L’Allier P, Segal E, Maire S, Kouz S, Ross D, Vanasse A,

Nasmith J, Bogaty P. A Comparison of Outcomes of Patients with ST-Elevation Myocardial Infarction by Type of Hospital and Choice of Treatment: Results of a Quebec-Wide Systematic Field Evaluation (2008-2009). Can J Cardiol 2012;28(Suppl):S378-S379

40. Lambert LJ, Xiao Y, Rinfret S, L’Allier P, Maire S, Kouz S, Ross D, Segal E, Vanasse A,

Nasmith J, Bogaty P. Short Term Mortality in ST-Elevation Myocardial Infarction (STEMI) Patients treated With Primary Angioplasty (PPCI): A Province-Wide. Systemactic Field Evalution . Can J Cardiol 2012;28(Suppl):S379-S380

41. Lambert LJ, Brown K, Brophy JM, Nasmith J, Segal E, Rodés-Cabau J, Carroll C, Giguère

M, Bogaty P. Long-term Outcomes Of Patients With ST-Elevation Myocardial Infarction (STEMI) With And Without Reperfusion Therapy: Results Of A Systematic Province-wide Field Evaluation In Quebec. Circ Cardiovasc Qual Outcomes 2012;5:A37.

42. Lambert LJ, Boothroyd LJ, Spaziano M, Guertin JR, Rodés-Cabau J, Noiseux N, Nguyen

M, Dumont E, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty P. Where Clinical Practice, Emerging Medical Technology, And Evaluation Intersect In A Healthcare System Based On Equal Access: The Example Of Transcatheter Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes 2012;5:A261.

43. Lambert LJ, Xiao Y, Kouz S, Rinfret S, Ross D, Segal E, L'Allier Philippe L, Maire S,

Vanasse A, Carroll C, Beauchamp C, Giguère M, Bogaty P. The Importance Of Assessing Inter-regional Systems Of Healthcare In Patients With ST-Elevation Myocardial Infarction (STEMI): Examples From A Systematic Field Evaluation. Circ Cardiovasc Qual Outcomes 2012;5:A195

44. Bogaty P, Xiao Y, Nasmith J, Segal E, Kouz S, Rinfret S, L’Allier P, Ross d, Vanasse A

Maire S, Lambert L. Under the Radar: Deaths From ST-Elevation Myocardial Infarction That Do Not Appear in Registries. Circulation 2011;124(Suppl A):1280.


of 44

45. Lambert L, Sas G, Boothroyd LJ, Guertin JR, Carrier M, Cecere R, Charbonneau E, Ducharme A, Bogaty P. A New Model For Evalating Emerging Technologies: The Example Of Ventricular Assist Devices. CCS 2011; Can J Cardiol 2011;27(Suppl):S257.

46. Lambert L, Xiao Y, Boothroyd L, Segal E, Ross D, Maire S, Kouz S, L’Allier P, Rinfret S,

Vanasse A, Bogaty P. The Introduction of Prehospital ECGs Into a Provincial System of ST-Elevation Myocardial Infarction (STEMI) Care: Impact on Treatment Delays And the Process of Care. CCS 2011; Can J Cardiol 2011;27(Suppl):S62-S63.

47. Lambert L, Ross D, Segal E, Maire S, L’Allier P, Vanasse A, Rinfret S, Kouz S, Bogaty P.

Centers that perform primary percutaneous coronary intervention without on-site cardiac surgery in a system of care of patients with ST-elevation myocardial infarction: Results from a systematic province-wide field evaluation Can J Cardiol 2011;27(Suppl):S61-S62.

48. Lambert L, Brown K, Brophy JM, Roges-Cabau J, Segal E, Bogaty P. Long-Term

outcomes of Patients With ST-Elevation Myocardial Infarction With And Without ReperfusionTherapy: Results from a systematic, province-wide field evaluation in Quebec. Can J Cardiol 2011;27(Suppl):S61.

49. Lambert L, Chakor H, Ross D, Segal E, Xiao Y, Vanasse A, Maire S, Kouz S, Rinfret S,

L'Allier P, Bogaty P. Teasing Out Why Reperfusion Therapy Was Not Given to a Substantial Number of Patients With ST-Elevation Myocardial Infarction (STEMI): A Classification Tool Developed From a Province-Wide Systematic Field Evaluation. Can J Cardiol 2011;27(Suppl):S145.

50. Lambert L, Ross D, Segal E, Maire S, L’Allier P, Vanasse a, Rinfret S, Kouz S, Chakor H,

Bogaty P. Patients With ST-Elevation Myocardial Infarction Sent For Primary Percutaneous Coronary Intervention And Who do Not Receive it: Results From a Systematic Province-Wide Evaluation. Can J Cardiol 2011;27(Suppl):S63.

51. Lambert L, Boothroyd LJ, Xiao Y, Caroll C, Giguere M, Bogaty P. Characteristics of

Practice of Primary Angioplasty Across 13 PCI Centers in Quebec (2008-2009): A Province-Wide Systematic Field Evaluation. Can J Cardiol 2011;27(Suppl):S62.

52. Bogaty P, Xiao Y, Nasmith J, Segal E, Kouz S, Rinfret S, L'Allier P, Ross D, Vanasse A,

Maire S, Lambert L. Under the Radar: Deaths From ST-Elevation Myocardial Infarction That Do Not Appear in Registries. Can J Cardiol 2011;27(Suppl):S63.

53. Lambert L, Xiao Y, L’Allier P, Kouz S, Rinfret S, Ross D, Segal E, Maire S, Vanasse A,

Bogaty P. Characteristics of practice of primary angioplasty in the province of Quebec, Canada (2008-2009): A systematic field evaluation. Circ Cardiovasc Qual Outcomes 2011;4:AP102.

54. Lambert L, Xiao Y, Boothroyd L, Segal E, Ross D, Maire S, Kouz S, L’Allier P, Rinfret S, Vanasse A, Bogaty P. The introduction of prehospital ECGs into a provincial system of ST-elevation myocardial infarction (STEMI) care : Impact on treatment delays and the process of care. Circ Cardiovasc Qual Outcomes 2011;4:AP123

55. Brown KA, Lambert LJ, Nasmith J, Segal E, Carroll C, Giguere M, Bogaty P. Why do some

Patients Not Receive ReperfusionTherapy For ST-Elevation Myocardial Infarction (STEMI)? A Field Evaluation With Expert Core Laboratory Electrocardiographic Analysis. Circ Cardiovasc Qual Outcomes 2011;4:AP318.

56. Doucette K, Brophy JM, Boyer L, Simard S, Dagenais GR, Bogaty P. Can recurrent acute

coronary events be predicted by C-reactive protein measurements in the previous six weeks? Can J Cardiol 2010;26 (Suppl D):121D.


of 44

57. Brown KA, David K, Lambert LJ, Bogaty P. Reliability of the assessment of patient comorbidities using Quebec’s medico-administrative data. Can J Cardiol 2010;26 (Suppl D):29D.

58. Lambert LJ, Poliquin S, Brown KA, Moutquin J, Carrier M, Langlois Y, Mathieu P,

Dendukuri N, Morin JE, Guertin J, Bogaty P. A coronary artery bypass graft surgery (CABG) evaluation project : by, for, and with cardiac surgeons. Can J Cardiol 2010;26 (Suppl D):29D.

59. Brown KA, David K, Lambert LJ, Bogaty P. Can Quebec’s hospital inpatient and day

surgery database (Med-Écho) be used to count Percutaneous Coronary Interventions (PCI) In Quebec ? Can J Cardiol 2010;26 (Suppl D):28D.

60. Lambert LJ, Brown KA, Carroll C, Segal E, Ross D, Lefrançois D, Smith W, Maire S,

Giguère M, Guertin JR, Boothroyd L, Bogaty P. Systems of care for ST-elevation myocardial infarction (STEMI) : An evaluation model for the province of Quebec. Can J Cardiol 2010;26 (Suppl D):128D.

61. Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P. Portrait of

Treatment of Myocardial Infarction with ST-Elevation (STEMI) in PCI-Capable Hospitals in Quebec, Canada: Mode of Reperfusion and Treatment Delays. Circ Cardiovasc Qual Outcomes 2009;2:e40.

62. Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert M, Boyer L, Madore F. sFAS improves

diagnostic accuracy for acute coronary syndromes in patients presenting with chest pain. Can J Cardiol 2008;24(Suppl SE):809


Thrombolytic Treatment for Myocardial Infarction withST-Elevation (STEMI) in Quebec, Canada: A Province-Wide Field Evaluation. Circ Cardiovasc Qual Outcomes 2009;2:e9

64. Lambert L, Simard S, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Bogaty P.

Reliability of Process Measures of Care of Patients Presenting with ST-Elevation Myocardial Infarction (STEMI) Abstracted by Hospital Health Record Librarians: Results of a Field Evaluation in Quebec, Canada. Circ Cardiovasc Qual Outcomes 2009;2:e40.


Delays for Transfers of Patients With ST-Elevation Myocardial Infarction (STEMI) for Primary PCI in Quebec, Canada : A Step-by-Step Analysis. Circ Cardiovasc Qual Outcomes 2009;2:e40

66. Lambert L, Carroll-Bilodeau C, Giguere M, Morin J, Boothroyd L, Nasmith J, Bogaty P.

Identification of Appropriate Patients for Inclusion in Process Measures of Care of Myocardial Infarction with ST-Elevation (STEMI). Circ Cardiovasc Qual Outcomes 2009;2:e9.

67. St-Germain C, Hanley J, Bogaty P, Boyer L, Engert JC, Brophy JM. Genetic Polymorphism

and the cardiovascular risk of Cyclooxygenase-2 inhibitors. J Am Coll Cardiol 2008;51(Suppl1):A195.

68. Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, Huynh T, Bertrand F,

Dagenais GR, Brophy JM. Does the pattern of serial values of C-Reactive Protein predict outcome in patiens with acute coronary disease? The RISCA Study. J Am Coll Cardiol 2008;51(Suppl 1):A219.


of 44

69. Cardinal H, Madore F, Brophy J, Bogaty P. The Therapeutic Impact of Renal Failure in Patients who Experience an Acute Coronary Syndrome: Are We Undertreating a Higher-Risk Subset? J Am Soc Nephrol 2007, vol 18, p.584-A.

70. Lambert LJ , Bogaty P, Baillot R, Morin JE, Cartier R, Brophy JM. Coronary artery bypass

surgery and associated mortality in the Quebec elderly, 1993-2004. Can J Cardiol 2007;23(Suppl C):492.

71. Lambert LJ, JM Brophy, JE Morin, P Bogaty. Percutaneous coronary intervention and

associated mortality in the Quebec elderly, 1993-2004. Can J Cardiol 2007;23(Suppl C):115.

72. Noel M, Marcoux A, Boyer L, Simard S, Bertrand F, Bogaty P. Transient increase in blood

inflammatory makers following intense exercise in healthy elderly men. Can J Cardiol 2007;23(Suppl C):795.

73. Côté J, Bertrand O, Rodes-Cabau J, Bogaty P, Champagne J, Brochu B, Miro S, Barbeau

G, Noël B, Poirier P, Despres J, Larose E. Epicardial fat measured during routine cardiovascular magnetic resonnance predicts coronary artery disease. Can J Cardiol 2007;23(Suppl C):893.

74. Larose E, Côté J, Rodes-Cabau J, Bogaty P, Champagne J, Brochu B, Miro S, Noël B,

Poirier P, Bertrand O, Despres J. Epicardial fat measured during routine cardiovascular magnetic resonnance predicts coronary artery disease. J Cardiovasc Magn Res 2007;9(Suppl 1):443.

75. Cardinal H, Brophy J, Bogaty P, Brassard N, Madore F. Do Soluble FAS and Endothelial

Apoptotic Microparticles predict recurrent cardiovascular events in patients with an acute coronary syndrome. Can J Cardiol 2007;23(Suppl C):797.

76. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Low flow, low gradient severe aortic

stenosis despite preserved ejection fraction: a paradoxical patter that is associated with higher LV afterload and increased mortality. Eur Heart J 2007;28(Suppl I):3405.

77. Garceau P, Noël M, Samson M,, Poirier P, Bogaty P. Impact of altitude-induced

hypoxemia on myocardial function in healthy climbers. Can J Cardiol 2007;23(Suppl C):149.

78. Noel M, Cabau JR, Rivest D, Mackey A, Houde C, Cote J, Chetaille P, Delisle G, Bogaty P,

Bertrand OF. The impact of atherosclerotic burden in cryptogenic stroke of young patients with and without paten foramen ovale. Can J Cardiol 2007;23(Suppl C):364.

79. Noel M, Jobin J, Poirier P, Dagenais G, Bogaty P. Less myocardial ischemia on the

ergocycle than on the treadmill: Is it the exercise protocol or the machine. Can J Cardiol 2007;23(Suppl C):913.

80. Brassard P, Legault S, Garneau C, Bogaty P, JG Dumesnil JG, Poirier P. Aerobic exercise

training reverses diastolic dysfunction uncomplicated well-controlled type 2 diabetes. Diabetes 2007;56(Suppl 1):277A.

81. Bogaty P, Dauwe F, Boyer L, Simard S, Dupuis R, Verret B, Huynh T, Roux R, d'Astous

M, Bertrand F, Dagenais GR, Brophy J. Does C-Reactive protein at admission, discharge or one month have incremental clinical value to predict outcome in patients with acute coronary disease. J Am Coll Cardiol 2007; 49(Suppl 1):199A.


of 44

82. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer prognosis: implications for diagnosis and treatment. Circulation 2006;114(Suppl II):II-714.

83. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe

aortic stenosis despite preserved ejection fraction reflects more severe disease and poorer prognosis: implications for diagnosis and treatment. Can J Cardiol 2006;22(Suppl D):218D.

84. Noël M, Jobin J, Marcoux A, Boyer L, Bogaty P. Does sustained ischemic exercise cause

myocardial damage? Circulation 2005;112 :II-811 85. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. ACE-DD genotype is

associated with endothelial dysfunction in postmenopausal women. Circulation 2005;112 :II-202.

86. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Does a gradual exercise test ramp

attenuate myocardial ischemia? J Am Coll Cardiol 2005;45(Suppl A):211A-212A . 87. Dagenais GR,Gilbert P, St-Pierre AC, Lamarche B, Després JP, Bogaty P. Long-term

cardiovascular consequences of diabetes among Quebec men, The Quebec Cardiovascular Study. Can J Cardiol 2005;21(Suppl C):222C.

88. Dagenais GR,Gilbert P, St-Pierre AC, Lamarche B, Després JP, Bogaty P. Long-term

disastrous impact of tobacco among Quebec men, The Quebec Cardiovascular Study. Can J Cardiol 2005;21(Suppl C):137C.

89. Bogaty P, Brophy JM, Noël M et al. Impact of prolonged Cyclooxygenase-2 inhibition on

inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: A randomized placebo-controlled study. ACC Current Journal Review 2004 page 13.

90. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Plante S, Poirier P. ACE-DD genotype is

associated with endothelial dysfunction in postmenopausal women. Can J Cardiol 2005;21:113C.

91. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. Does ACE-DD genotype

play a role on the timing acute coronary events during the menstrual cycle in premenopausal women? Can J Cardiol 2005;21:233C.

92. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. Does a gradual exercise test (RAMP)

attenuate myocardial ischemia? Clin Invest Med 2005;28; 26. 93. Méthot J, Hamelin BA, Arsenault M, Bogaty P, Poirier P. Does renin angiotensin system

genotypes is associated with flow-mediated dilatation of the brachial artery in postmenopausal? Can J Diabetes 2004;28:306.

94. Noël M, Jobin J, Poirier P, Dagenais GR, Bogaty P. L’ischémie myocardique induite à

l’effort: différence marquée entre l’ergocycle et le tapis roulant? Med Sci 2004;20:21. 95. Ferland A, Turbide G, Bogaty P, Jobin J, Larivière MM, Poirier P. Type 2 diabetes and

aerobic exercise – Is prior breakfast deleterious? Med Sci Sports Exerc 2004;36:2281. 96. Pilote B, Bogaty P, Lacourcière Y, Ferland A, Poirier P. Relation entre la tension artérielle

exagérée à l’effort et le monitorage de la tension artérielle chez les diabétiques de type 2. Med Sci 2003;19 (Suppl 1):16.


of 44

97. Pilote B, Bogaty P, Ferland A, Lacourcière Y, Poirier P. Association between exaggerated blood pressure response to exercise and cardiac autonomic nervous system modulation in men with type 2 diabetes free of heart disease. Am J Sports Med 2003;5:182.

98. Méthot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P GR. Difference in the

clinical presentation of acute coronary syndrome between premenopausal and postmenopausal women. Circulation 2002;106 (Suppl II):II-540.

99. Méthot J, Hamelin BA, Bogaty P, Aresenault M, Plante S, Poirier P. ACE-DD genotype is

associated with the occurrence of acute Coronary syndrome in postmenopausal women, Can J Cardiol 2002;19 (Suppl A):248A.

100. Méthot J, Poirier P, Bogaty P, Arsenault M, Plante S and Hamelin BA. Does renin

angiotensin polymorphisms in postmenopausal women impact the occurrence of acute coronary syndrome? Can J Cardiol 2002;18 (Suppl B):211B.

101. Pilote B, Bogaty P, Lacourcière Y, Ferland A, Brochu C, Poirier P. Relationship between

exaggerated blood pressure response to exercise and ambulatory blood pressure in patients with type 2 diabetes. Can J Cardiol 2002;18 (Suppl B):213B.

102. Bogaty P, Boyer L, Simard S, Bertrand F, Hamelin B, Dagenais GR. P-Selectin as a

marker of acute coronary artery disease risk independent of C-reactive protein. Circulation 2001;104 (Suppl II):II-636.

103. Bogaty P, Poirier P, Boyer L, Auclair L, Pepin G, Jobin J, Arsenault M. Relation of serial

changes in endothelial function, exercise ischemic parameters, and blood markers in subjects with stable angina undergoing aggressive lipid-lowering: The Can-ADA endothelial dysfunction substudy. Circulation 2001;104 (Suppl II):II-446.

104. Dagenais GR, Auger P, Bogaty P, Bosch J, Gerstein HC, Lonn E, Yi Q, Yusuf S. Impact of

Abdominal Obesity on the Occurrence of Diabetes in Subjects with Ischemic Cardiovascular Disease. Circulation 2001;104 (Suppl II):II-833.

105. Bogaty P, Boyer L, Rousseau L, Arsenault M. Is anteroseptal myocardial infarction an

appropriate term? Circulation 2000;102 (Suppl II):II-793-4. 106. Methot J, Bogaty P, Poirier P, Arsenault M, Pilote S, Plante S, Hamelin BA. The

relationship of the occurrence of acute coronary events in women to the timing of their menstrual cycle. Circulation 2000;102 (Suppl II):II-613.

107. Bogaty P, Poirier P, Boyer L, Auclair L, Jobin J. What induces warm-up angina: exercise or

myocardial ischemia? Circulation 2000;102 (Suppl II):II-522. 108. Bogaty P, Boyer L, Arsenault M. Is the electrocardiographic anteroseptal myocardial

infarction really anteroseptal? Can J Cardiol 2000;16 (Suppl F):157F. 109. Bogaty P, Leiter L, Murray P, Angus C, on behalf of the Can-ADA Study Investigators. The

Can-ADA Study: Do lipid parameters respond differently to atorvastatin therapy in ischemic heart disease subjects with and without type 2 diabetes? Can J Cardiol 2000;16 (Suppl F):234F.

110. Bogaty P, Poirier P, Boyer L, Auclair L, Jobin J. What induces warm-up angina: exercise or

myocardial ischemia? Can J Cardiol 2000;16 (Suppl F):192F.


of 44

111. Huynh T, Théroux P, Nasmith J, Bogaty P, Solymoss S. Aspirin, warfarin and their

combination in secondary prevention of patients with non-ST elevation coronary syndromes and a prior coronary artery bypass surgery. Can J Cardiol 2000;16 (Suppl F):139F.

112. Baillot P, Bogaty P, Lemieux M, Doyle D, Bauset R, Desaulniers D, Métras J, Perron J,

Raymond G, Cartier P, Brochu H, Simard S. Dissociation between short-term morbidity and mortality in diabetic women undergoing coronary artery bypass. The First International Conference on Women, Heart Disease and Stroke. Victoria, BC, May 7-10, 2000. Can J Cardiol 2000;16 (Suppl B):33B.

113. Bogaty P, Poirier P, Boyer L, Simard S, Bertrand F, Dagenais GR. Is C-reactive protein a

marker for first and recurrent acute coronary events in very different subsets of stable ischemic heart disease? J Am Coll Cardiol 2000;35:313A.

114. Bogaty P, O'Hara GE, Boyer L, Auclair L, Arsenault M, Leblanc MH, Boudreault JR. A

novel non-invasive short hospital stay strategy for patients with low risk myocardial infarction: six month follow-up. J Am Coll Cardiol 2000;35:347A.

115. Poirier P, Garneau C, Bogaty P, Fortin C, Marois L, Phillipon F, Dumesnil JG. Preclinical

diabetic cardiomyopathy: association between asymptomatic left ventricular dysfunction and sub-clinical cardiac autonomic neuropathy in men with type 2 diabetes J Am Coll Cardiol 2000;35:208A.

116. Méthot J, Bogaty P, Poirier P, Arsenault M, Simard J, Plante S, Robitaille NM and Hamelin

BA: Association of polymorphisms in the renin-angiotensin system with acute coronary events in women. Pharmacotherapy 2000;20:1271.

117. Bogaty P, Hamelin B, Charbonneau L, Dion B, Boyer L, Kingma Jr JG. Is adenosine the

mediator of warm-up angina? Circulation 1999;100 (suppl):I-506. 118. Bogaty P, O'Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Leblanc MH, Boudreault

JR. A short hospital stay strategy for patients with low risk myocardial infarction: six month follow-up. Can J Cardiol 1999;15 (Suppl):135D.

119. Bogaty P, Poirier P, Boyer L, Simard S, Bertrand F, Dagenais GR. Is C-reactive protein a

marker for first and recurrent acute coronary events in stable ischemic heart disease subjects? Can J Cardiol 1999;15 (Suppl):131D.

120. Bogaty P, Hamelin B, Charbonneau L, Dion B, Boyer L, Kingma Jr JG. Is Adenosine the

mediator of warm-up angina. Can J Cardiol 1999;15 (Suppl):224D. 121. Dumont S, Jobin J, Boudreault JR, Dion B, Auclair L, Bélanger J, O'Hara GE, Bogaty P.

Psychological Impact of a Short Stay Strategy for Low Risk Myocardial Infarction Patients. Can J Cardiol 1999;15 (Suppl):225D.

122. Bogaty P, Guimond J, Kingma Jr JG, Robitaille N-M, Charbonneau L, Dagenais GR. The

relation of myocardial perfusion findings to the attenuation of myocardial ischemia observed with repeated exercise. Circulation 1998;98 (suppl):I-708-9.

123. Bogaty P, O’Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Lebanc M-H, Augustin C-E,

Boudreault J-R. Short hospital stay for uncomplicated myocardial infarction. Circulation 1998;98 (suppl):I-630-1.


of 44

124. Bogaty P, Turgeon J, Solymoss S, Poirier P, Boyer L, Simard S, Dagenais GR. Biological profile in subjects with multiple acute coronary events compared to longstanding stable angina. Circulation 1998;98 (suppl):I-765.

125. Bogaty P, Guimond J, Kingma Jr JG, Charbonneau L, Robitaille N-M, Dagenais GR.

Attenuation of myocardial ischemia with re-exercise: relation to perfusion findings. Can J Cardiol 1998;14 (Suppl F):85F.

126. Bogaty P, O’Hara GE, Dion B, Auclair L, Boyer L, Arsenault M, Augustin E, Boudreault J-R.

Short hospital stay for uncomplicated myocardial infarction. Can J Cardiol 1998;14 (Suppl F):85F.

127. Bogaty P, Turgeon J, Solymoss S, Poirier P, Boyer L, Simard S, Dagenais GR. Biological

profile in subjects with multiple acute coronary events compared to longstanding stable angina. Can J Cardiol 1998 (Suppl F);14:116F.

128. Kingma JG Jr, Plante S, Bogaty P. Blockade of the platelet glycoprotein IIb/IIIa receptor

reduces infarct size in a canine model of myocardial infarction and reperfusion. J Am Coll Cardiol 1998; 31 (suppl A):135A.

129. Hamelin BA, Pham D, Desgagnés V, Rail J, Bogaty P, Morin J, Turgeon J. CYP2D6

ultrarapid metabolism and response to metoprolol. Am Coll Clin Pharm 1997 Annual Meeting.

130. Bogaty P, Theroux P, for the FRSQ Quebec Acute Coronary Care Working Group. Who

dies in the hospital with an acute coronary syndrome? A contemporary profile from the Quebec Acute Coronary Registry. Circulation 1997;96(Suppl):I-261.

131. Bogaty P, Solymoss S, Boyer L, Auger D, Simard S, Rail J, Léveillée J, Turgeon J.

Hemostatic and inflammation profile and angiotensin-converting enzyme (ACE) genotype in subjects with a history of multiple acute coronary events. Can J Cardiol 1997;13(Suppl C):107C.

132. Bogaty P, Theroux P, for the FRSQ Quebec Acute Coronary Care Working Group. A

contemporary profile of who dies in the hospital with an acute coronary syndrome: the Quebec Acute Coronary Registry. Can J Cardiol 1997;13(Suppl C):131C.

133. Solymoss S, Bogaty P, Boyer L, Auger D, Lipman M, Kwan J. Decreasing activated protein

C resistance ratio correlates with known risk markers in subjects with acute and chronic ischemic heart disease. Thromb Haemost 1997;78(Suppl):312.

134. Bogaty P, Robitaille N-M, Boyer L, Auger D, Solymoss S, Turgeon J. Hemostatic and

inflammatory parameters in subjects with previous unheralded myocardial infarction compared to longstanding uncomplicated stable angina. The 4th International Conference on Preventive Cardiology, Montreal, 1997. Can J Cardiol 1997;13 (Suppl B):308B.

135. Bogaty P, Robitaille N-M, Charbonneau L, Plante S, Kingma J. Does glibenclamide block

the attenuation of myocardial ischemia observed with repeated exercise in subjects with ischemic heart disease? Diabetes 1997;46 (Suppl 1):256A.

136. Bogaty P, Plante S, Rossignol G, Plante M, Rouleau JR, Kingma JG Jr. Rapid cardiac

pacing in the presence of a flow-limiting coronary stenosis does not precondition sufficiently to limit infarct size. FASEB 1997;12:279A.

137. Bogaty P, Robitaille N-M, Charbonneau L, Plante S, Kingma JG Jr. Role of ATP-sensitive

potassium channels in exercise-induced ischemic preconditioning. Can J Cardiol 1996;12(Suppl E):139E.


of 44

138. Bogaty P, Plante S, Rossignol G, Plante M, Rouleau JR, Kingma JG Jr. Effect of demand-

induced myocardial ischemia on infarct size in a novel porcine model. Can J Cardiol 1996;12 (Suppl E):160E.

139. Bogaty P, Robitaille N-M, Plante S, Charbonneau L, Beauchemin J, Kingma JG, Dumesnil

JG. Characterization of exercise-induced ischemic preconditioning and its relation with left ventricular wall motion. Circulation 1995;92 (Suppl):I-736.

140. Bogaty P, Robitaille N-M, Labbé, L, Boyer L, Harnois J, Auger D, Coulombe D, Turgeon J.

Genotype distribution of the angiotensin-converting enzyme insertion/deletion polymorphism (I/D) in unheralded myocardial infarction and uncomplicated chronic stable angina. Can J Cardiol 1995;11 (Suppl E):75E.

141. Murè P, Bogaty P, Dumesnil JG. Immediate echocardiography in acute left heart failure:

implications regarding pathogenetic mechanisms. Can J Cardiol 1995;11 (Suppl E):74E. 142. Marceau D, Duchesneau K, Bogaty P. Risks of the totally implanted central venous

catheter in cancer patients: relation to tumour type. Support Care Cancer 1995;3:372. 143. Bogaty P, Brecker SJ, White SE, Stevenson RN, El-Tamimi H, Balcon R, Maseri A. A

comparison of coronary angiographic findings at acute and chronic first presentation of ischemic heart disease. ACC Curr J Rev 1994;3:9-10.

144. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, Turgeon J. Genotype

distribution of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism differs among young cardiac and young healthy Canadian subjects. Circulation 1994;90 (Suppl):I-110.

145. Bogaty P, Guimond J, Rousseau L, Robitaille N-M, Rouleau JR.Angiographic and

scintigraphic correlates of early positivity, ischemic threshold and recovery time in exercise testing in patients with coronary artery disease. Circulation 1994;90 (Suppl):I-329.

146. Robitaille NM, Bogaty P, Asselin MJ, Genest M, Labbé L, Lefez C, Turgeon J. Genotype

distribution of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism differs among young cardiac and young healthy subjects. Can J Cardiol 1994;10 (Suppl C):73C.

147. Bogaty P, Guimond J, Rousseau L, Robitaille NM, Rouleau JR. Does an early positive

exercise test or a prolonged recovery time signify more severe ischemic heart disease ? Can J Cardiol 1994;10 (Suppl C):102C.

148. Marceau D, Bogaty P. The role of the media and public opinion in transforming hospital

policies regarding terminal care. Support Care Cancer 1994;2. 149. Bogaty P, Guimond J, Rousseau L, Rouleau JR. Does more ST segment depression on

the 12 lead exercise electrocardiogram signify more severe ischemic heart disease? Circulation 1993;88 (Suppl):I-22.

150. Bogaty P, Davies G, Hackett D, Crake T, Kooner J, Haider AW, Maseri A. Culprit lesion

and downstream vasoreactivity in unstable angina. Circulation 1993;88 (Suppl):I-609. 151. Bogaty P, Kaski JC, Gavrielides S, Tousoulis D, Rouleau J, Maseri A. Recovery time of ST

segment depression correlates with both magnitude of depression at peak exercise and rate-pressure product during recovery. J Am Coll Cardiol 1992;19 (Suppl):96A.


of 44

152. Athanassopoulos G, Joshi J, Marsonis A, Bogaty P, Oakley CM, Nihoyannopoulos P. Significance of delayed recovery following digital exercise echocardiography and temporally related ECG changes. Eur Heart J 1991;12 (suppl):399.

153. Galassi A, Kaski JC, Tousoulis D, Bogaty P, Gavrielides S, Crea F, Maseri A. Patterns of

heart rate during exercise testing and ambulatory electrocardiographic monitoring in patients with Syndrome X. Eur Heart J 1991;12 (suppl):121.

154. Bogaty P, Kaski JC, Gavrielides S, Tousoulis D, Maseri A. Recovery time of ST segment

depression is related to magnitude of depression at peak exercise. Eur Heart J 1991;12 (suppl):329.

155. Bogaty P, Brecker SJ, White SE, El-Tamimi H, Stevenson RN, Balcon R, Maseri A. The

extent of coronary atherosclerosis is very different in unheralded acute myocardial infarction compared to uncomplicated chronic stable angina. Br Heart J 1991;66:57.

156. Bogaty P, Brecker SJ, White SE, El-Tamimi H, Stevenson RN, Balcon R, Maseri A.

Different coronary angiographic findings in unheralded acute myocardial infarction and uncomplicated chronic stable angina. J Am Coll Cardiol 1991;17 (suppl A):254A.

157. Tousoulis D, Kaski JC, Crea F, Gavrielides S, Galassi A, Bogaty P, Maseri A. Reactivity of

proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina. Eur Heart J 1990;11 (suppl):146.

158. Dagenais GR, Bogaty P, Cantin B, Rouleau JR, Dumesnil JG. Does the workload achieved

predict coronary heart events in patients with painless strongly positive exercise test ? Eur Heart J 1988;9 (Suppl I): 345.

159. Bogaty P, Dagenais GR, Cantin B, Rouleau JR. Does the exercise test predict acute

ischemic cardiac morbid events in patients with strongly positive exercise electrocardiogram? Circulation 1988;78 (Suppl II):108.

pbogaty cv 2015-01-19 cliniccliniquecardiomontreal.com/bogatycv.pdf · cv peter bogaty en date du...

Documents